<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle"><p class="DocumentTitle"><strong><span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">INFLUENZA</span> A (H1N1) 2009 MONOVALENT VACCINE- <span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">influenza</span> a virus a/california/7/2009(h1n1)-like hemagglutinin antigen (propiolactone inactivated) injection, suspension </strong><br>Novartis Vaccines and Diagnostics Ltd<br></p></div>
<div id="Highlights" class="Highlights"><table cellspacing="5" cellpadding="5" width="100%" style="table-layout:fixed"><tr><td align="left" valign="top"><div>
<h1>HIGHLIGHTS OF PRESCRIBING INFORMATION</h1>
<div class="HighlightsDisclaimer"><span class="Bold">These highlights do not include all the information needed to use <span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">Influenza</span> A (H1N1) 2009 Monovalent Vaccine safely and effectively. See full prescribing information for <span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">Influenza</span> A (H1N1) 2009 Monovalent Vaccine.
			<br><br><span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">Influenza</span> A (H1N1) 2009 Monovalent Vaccine
			<br>Manufactured by Novartis Vaccines and Diagnostics Ltd.
			<br>Suspension for Intramuscular Injection 
			<br>Initial U.S. Approval: 2009
		</span></div>
<div></div>
<div class="HighlightSection">
<h1 class="Highlights"><span>INDICATIONS AND USAGE</span></h1>
<div><ul class="Disc"><li><span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">Influenza</span> A (H1N1) 2009 Monovalent Vaccine is an inactivated <span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">influenza</span> virus vaccine indicated for active immunization of persons 4 years of age and older against <span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">influenza</span> disease caused by pandemic (H1N1) 2009 virus (<a href="#s1">1</a>).
</li></ul></div>
</div>
<div class="HighlightSection">
<h1 class="Highlights"><span>DOSAGE AND ADMINISTRATION</span></h1>
<div>
<p class="Highlighta"><span class="Bold">Based on currently available information the vaccination regimen is as follows:</span> </p>
<ul class="Disc">
<li>
<span class="Bold">Children 4 through 9 years of age</span>: Two 0.5-mL intramuscular injections approximately 1 month apart (<a href="#s4">2.2</a>)
</li>
<li>
<span class="Bold">Children 10 through 17 years of age:</span> A single 0.5-mL intramuscular injection (<a href="#s4">2.2</a>)
</li>
<li>
<span class="Bold">Adults 18 years of age and older:</span> A single 0.5-mL intramuscular injection (<a href="#s4">2.2</a>)
</li>
</ul>
</div>
<div></div>
<div>
<div></div>
<div></div>
</div>
</div>
<div class="HighlightSection">
<h1 class="Highlights"><span>DOSAGE FORMS AND STRENGTHS</span></h1>
<div>
<p class="Highlighta"><span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">Influenza</span> A (H1N1) 2009 Monovalent Vaccine, a sterile suspension for intramuscular injection, is supplied in two presentations:
 </p>
<ul class="Disc">
<li>Prefilled single dose syringe, 0.5-mL. Thimerosal, a mercury derivative used during manufacture, is removed by subsequent purification steps to a trace amount (≤ 1 mcg mercury per 0.5-mL dose) (<a href="#s7">3</a>, <a href="#s32">11</a>)
</li>
<li>Multidose vial, 5-mL. Contains thimerosal, a mercury derivative (25 mcg mercury per 0.5-mL dose).  Thimerosal is added as preservative. (<a href="#s7">3</a>,<a href="#s32">11</a>)
</li>
</ul>
</div>
</div>
<div class="HighlightSection">
<h1 class="Highlights"><span>CONTRAINDICATIONS</span></h1>
<div><ul class="Disc"><li>History of systemic <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity reactions</span> to egg proteins, or any other component of <span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">Influenza</span> A (H1N1) 2009 Monovalent Vaccine, or life-threatening reactions to previous <span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">influenza</span> vaccinations. (<a href="#s8">4</a>, <a href="#s32">11</a>)
</li></ul></div>
<div></div>
</div>
<div class="HighlightSection">
<h1 class="Highlights"><span>WARNINGS AND PRECAUTIONS</span></h1>
<div><ul class="Disc">
<li>If Guillain-Barré syndrome has occurred within 6 weeks of receipt of prior <span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">influenza</span> vaccine, the decision to give <span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">Influenza</span> A (H1N1) 2009 Monovalent Vaccine should be based on careful consideration of the potential benefits and risks. (<a href="#s11">5.1</a>)
</li>
<li>Immunocompromised persons may have a reduced immune response to <span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">Influenza</span> A (H1N1) 2009 Monovalent Vaccine. (<a href="#s12">5.2</a>)
</li>
</ul></div>
<div></div>
<div></div>
<div></div>
<div></div>
</div>
<div class="HighlightSection">
<h1 class="Highlights"><span>ADVERSE REACTIONS</span></h1>
<div>
<p class="Highlighta">Adverse Reaction information is based on studies conducted with seasonal trivalent <span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">Influenza</span> Virus Vaccine manufactured by Novartis (FLUVIRIN).
 </p>
<p class="Highlighta">The most frequently reported adverse reactions are mild <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity reactions</span> (such as <span class="product-label-link" type="condition" conceptid="140214" conceptname="Eruption">rash</span>), local reactions at the injection site, and <span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">influenza</span>-like symptoms. (<a href="#s15">6</a>)
 </p>
<p class="Highlighta"><span class="Bold">To report SUSPECTED ADVERSE REACTIONS contact Novartis Vaccines at 1-800-244-7668, or VAERS at 1-800-822-7967 and
</span><span class="Bold Underline">www.vaers.hhs.gov</span>.
 </p>
</div>
<div></div>
<div>
<div></div>
<div></div>
<div></div>
<div></div>
</div>
<div></div>
<div></div>
</div>
<div class="HighlightSection">
<h1 class="Highlights"><span>DRUG INTERACTIONS</span></h1>
<div><ul class="Disc">
<li>Do not mix with any other vaccine in the same syringe or vial. (<a href="#s25">7.1</a>)
</li>
<li>Immunosuppressive therapies may reduce immune response to <span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">Influenza</span> A (H1N1) 2009 Monovalent Vaccine. (<a href="#s26">7.2</a>)
</li>
</ul></div>
<div></div>
<div></div>
</div>
<div class="HighlightSection">
<h1 class="Highlights"><span>USE IN SPECIFIC POPULATIONS</span></h1>
<div><ul class="Disc">
<li>Safety and effectiveness of <span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">Influenza</span> A (H1N1) 2009 Monovalent Vaccine have not been established in pregnant women, nursing mothers or children less than 4 years of age. (<a href="#s28">8.1</a>, <a href="#s29">8.3</a>, <a href="#s30">8.4</a>)
</li>
<li>Antibody responses to the trivalent seasonal <span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">Influenza</span> Virus Vaccine manufactured by Novartis (FLUVIRIN) were lower in the geriatric population than in younger subjects. (<a href="#s31">8.5</a>)
</li>
</ul></div>
<div></div>
<div></div>
<div></div>
</div>
<div></div>
<div><div></div></div>
<div><div></div></div>
<div>
<div></div>
<div></div>
<div></div>
</div>
<div></div>
<div>
<div></div>
<div></div>
</div>
<div></div>
<div></div>
<div></div>
<p class="HighlightsSeeReference">See 17 for PATIENT COUNSELING INFORMATION.</p>
<p class="HighlightsRevision">Revised: 9/2009</p>
</div></td></tr></table></div>
<div id="Index" class="Index"><table cellspacing="5" cellpadding="5" width="100%" style="table-layout:fixed"><tr><td align="left" valign="top"><div>
<h1 class="Colspan">FULL PRESCRIBING INFORMATION: CONTENTS<a href="#footnote-content" name="footnote-reference-content">*</a>
</h1>
<h1><a href="#section-1" class="toc">1 Indications and Usage
</a></h1>
<h1><a href="#section-2" class="toc">2 Dosage and Administration
</a></h1>
<h2><a href="#section-2.1" class="toc">2.1 Preparation for Administration
</a></h2>
<h2><a href="#section-2.2" class="toc">2.2 Recommended Dose and Schedule
</a></h2>
<h1><a href="#section-3" class="toc">3 DOSAGE FORMS AND STRENGTHS
</a></h1>
<h1><a href="#section-4" class="toc">4 CONTRAINDICATIONS
</a></h1>
<h2><a href="#section-4.1" class="toc">4.1 <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">Hypersensitivity</span>
</a></h2>
<h1><a href="#section-5" class="toc">5 WARNINGS AND PRECAUTIONS
</a></h1>
<h2><a href="#section-5.1" class="toc">5.1 Guillain-Barré Syndrome
</a></h2>
<h2><a href="#section-5.2" class="toc">5.2 Altered Immunocompetence
</a></h2>
<h2><a href="#section-5.3" class="toc">5.3 Preventing and Managing <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">Allergic Reactions</span>
</a></h2>
<h2><a href="#section-5.4" class="toc">5.4 Limitations of Vaccine Effectiveness
</a></h2>
<h1><a href="#section-6" class="toc">6 ADVERSE REACTIONS
</a></h1>
<h2><a href="#section-6.1" class="toc">6.1 Overall Adverse Reaction Profile
</a></h2>
<h2><a href="#section-6.2" class="toc">6.2 Clinical Trial Experience
</a></h2>
<h2><a href="#section-6.3" class="toc">6.3 Postmarketing Experience
</a></h2>
<h2><a href="#section-6.4" class="toc">6.4 Other Adverse Reactions Associated with <span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">Influenza</span> Vaccination
</a></h2>
<h1><a href="#section-7" class="toc">7 DRUG INTERACTIONS
</a></h1>
<h2><a href="#section-7.1" class="toc">7.1 Concomitant Administration with Other Vaccines
</a></h2>
<h2><a href="#section-7.2" class="toc">7.2 Concurrent Use with Immunosuppressive Therapies
</a></h2>
<h1><a href="#section-8" class="toc">8 USE IN SPECIFIC POPULATIONS
</a></h1>
<h2><a href="#section-8.1" class="toc">8.1 Pregnancy
</a></h2>
<h2><a href="#section-8.2" class="toc">8.3 Nursing Mothers
</a></h2>
<h2><a href="#section-8.3" class="toc">8.4 Pediatric Use
</a></h2>
<h2><a href="#section-8.4" class="toc">8.5 Geriatric Use
</a></h2>
<h1><a href="#section-9" class="toc">11 DESCRIPTION
</a></h1>
<h1><a href="#section-10" class="toc">12 CLINICAL PHARMACOLOGY
</a></h1>
<h2><a href="#section-10.1" class="toc">12.1 Mechanism of Action
</a></h2>
<h1><a href="#section-11" class="toc">13 NONCLINICAL TOXICOLOGY
</a></h1>
<h2><a href="#section-11.1" class="toc">13.1 Carcinogenesis, Mutagenesis, Impairment of Fertility
</a></h2>
<h1><a href="#section-12" class="toc">14 CLINICAL STUDIES
</a></h1>
<h2><a href="#section-12.1" class="toc">14.1 Immunogenicity in Adults (18 to 64 years of age)
</a></h2>
<h2><a href="#section-12.2" class="toc">14.2 Immunogenicity in Geriatric Subjects (65 years of age and older)
</a></h2>
<h2><a href="#section-12.3" class="toc">14.3 Immunogenicity in Pediatric Subjects
</a></h2>
<h1><a href="#section-13" class="toc">15 REFERENCES
</a></h1>
<h1><a href="#section-14" class="toc">16 HOW SUPPLIED/STORAGE AND HANDLING
</a></h1>
<h2><a href="#section-14.1" class="toc">16.1 How Supplied
</a></h2>
<h2><a href="#section-14.2" class="toc">16.2 Storage and Handling
</a></h2>
<h1><a href="#section-15" class="toc">17 PATIENT COUNSELING INFORMATION
</a></h1>
<dl class="Footnote">
<dt><a href="#footnote-reference-content" name="footnote-content">*</a></dt>
<dd>Sections or subsections omitted from the full prescribing information are not listed.</dd>
</dl>
</div></td></tr></table></div>
<div class="Contents">
<h1>FULL PRESCRIBING INFORMATION</h1>
<div class="Section" data-sectionCode="48780-1">
<a name="section-1"></a><p></p>
</div>
<div class="Section" data-sectionCode="34067-9">
<a name="s1"></a><a name="section-1"></a><p></p>
<h1>1 Indications and Usage
</h1>
<p class="First"> <span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">Influenza</span> A (H1N1) 2009 Monovalent Vaccine is an inactivated <span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">influenza</span> virus vaccine indicated for immunization of persons 4 years of age and older against <span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">influenza</span> disease caused by pandemic (H1N1) 2009 virus.
</p>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="s2"></a><a name="section-2"></a><p></p>
<h1>2 Dosage and Administration
</h1>
<div class="Section" data-sectionCode="42229-5">
<a name="s3"></a><a name="section-2.1"></a><p></p>
<h2>2.1 Preparation for Administration
</h2>
<p class="First">Inspect <span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">Influenza</span> A (H1N1) 2009 Monovalent Vaccine syringes and multidose vials visually for particulate matter and/or discoloration prior to administration.  If either of these conditions exists, the vaccine should not be administered.
</p>
<p>Shake the syringe vigorously before administering the vaccine and shake the multidose vial preparation each time before withdrawing a dose of vaccine.
</p>
<p>Between uses, return the multidose vial to the recommended storage conditions between 2º and 8ºC (36º and 46ºF).  <span class="Bold">Do not freeze.</span>  Discard if the vaccine has been frozen.
</p>
<p>A separate syringe and needle or a sterile disposable unit should be used for each injection to prevent transmission of infectious agents from one person to another.  Needles should be disposed of properly and not recapped.
</p>
<p><span class="Bold">It is recommended that small syringes (0.5-mL or 1-mL) should be used to minimize any product loss.</span></p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="s4"></a><a name="section-2.2"></a><p></p>
<h2>2.2 Recommended Dose and Schedule
</h2>
<p class="First">Clinical studies are ongoing with <span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">Influenza</span> A (H1N1) 2009 Monovalent Vaccine to determine the optimal dosage, number of doses and schedule.
</p>
<p>Available data show that children 9 years of age and younger are largely serologically naïve to the pandemic (H1N1) 2009 virus (15.1).  Based upon these data <span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">Influenza</span> A (H1N1) 2009 Monovalent Vaccine should be administered as follows:
</p>
<div class="Section" data-sectionCode="42229-5">
<a name="s5"></a><a name="section-2.2.1"></a><p></p>
<p class="First"><span class="Bold">Children (4 to 17 years of age):</span></p>
<p>Children 4 through 9 years of age should receive two 0.5mL doses by intramuscular injection approximately 1 month apart.
</p>
<p>Children 10 through 17 years of age should receive a single 0.5-mL intramuscular injection.
</p>
<p>The needle size may range from 7/8 to 1¼ inches, depending on the size of the child’s deltoid muscle, and should be of sufficient length to penetrate the muscle tissue. The anterolateral thigh can be used, but the needle should be longer, usually 1 inch.
</p>
<p>The vaccine should not be injected in the gluteal region or areas where there may be a major nerve trunk.
</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="s6"></a><a name="section-2.2.2"></a><p></p>
<p class="First"><span class="Bold">Adults (18 years of age and older):</span></p>
<p><span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">Influenza</span> A (H1N1) 2009 Monovalent Vaccine should be administered as a single 0.5-mL intramuscular injection preferably in the region of the deltoid muscle of the upper arm. 
</p>
<p>A needle of ≥1 inch is preferred because needles &lt;1 inch might be of insufficient length to penetrate muscle tissue in certain adults.
</p>
<p>The vaccine should not be injected in the gluteal region or areas where there may be a major nerve trunk.
</p>
</div>
</div>
</div>
<div class="Section" data-sectionCode="43678-2">
<a name="s7"></a><a name="section-3"></a><p></p>
<h1>3 DOSAGE FORMS AND STRENGTHS
</h1>
<p class="First"><span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">Influenza</span> A (H1N1) 2009 Monovalent Vaccine is a sterile suspension for intramuscular injection.  [see DESCRIPTION (<a href="#s32">11</a>) for the complete list of ingredients]
</p>
<p><span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">Influenza</span> A (H1N1) 2009 Monovalent Vaccine is available in two presentations:
</p>
<p>1) Prefilled single dose syringe, 0.5-mL. Thimerosal, a mercury derivative used during manufacture, is removed by subsequent purification steps to a trace amount (≤ 1 mcg mercury per 0.5-mL dose).
</p>
<p>2) Multidose vial, 5-mL. Contains thimerosal, a mercury derivative, added as a preservative.  Each 0.5-mL dose from the multidose vial contains 25 mcg mercury.
</p>
</div>
<div class="Section" data-sectionCode="34070-3">
<a name="s8"></a><a name="section-4"></a><p></p>
<h1>4 CONTRAINDICATIONS
</h1>
<div class="Section" data-sectionCode="42229-5">
<a name="s9"></a><a name="section-4.1"></a><p></p>
<h2>4.1 <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">Hypersensitivity</span>
</h2>
<p class="First"><span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">Influenza</span> A (H1N1) 2009 Monovalent Vaccine should not be administered to anyone with known systemic <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity reactions</span> to egg proteins (eggs or egg products), or to any component of <span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">Influenza</span> A (H1N1) 2009 Monovalent Vaccine, or who has had a life-threatening reaction to previous <span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">influenza</span> vaccinations [see DESCRIPTION (<a href="#s32">11</a>)].
</p>
</div>
</div>
<div class="Section" data-sectionCode="43685-7">
<a name="s10"></a><a name="section-5"></a><p></p>
<h1>5 WARNINGS AND PRECAUTIONS
</h1>
<div class="Section" data-sectionCode="42229-5">
<a name="s11"></a><a name="section-5.1"></a><p></p>
<h2>5.1 Guillain-Barré Syndrome
</h2>
<p class="First">If Guillain-Barré syndrome has occurred within 6 weeks of receipt of prior <span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">influenza</span> vaccine, the decision to give <span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">Influenza</span> A (H1N1) 2009 Monovalent Vaccine should be based on careful consideration of the potential benefits and risks.
</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="s12"></a><a name="section-5.2"></a><p></p>
<h2>5.2 Altered Immunocompetence
</h2>
<p class="First">If <span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">Influenza</span> A (H1N1) 2009 Monovalent Vaccine is administered to immunocompromised persons, including individuals receiving immunosuppressive therapy, the expected immune response may not be obtained.
</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="s13"></a><a name="section-5.3"></a><p></p>
<h2>5.3 Preventing and Managing <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">Allergic Reactions</span>
</h2>
<p class="First">Prior to administration of any dose of <span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">Influenza</span> A (H1N1) 2009 Monovalent Vaccine, the healthcare provider should review the patient’s prior immunization history for possible adverse events, to determine the existence of any contraindication to immunization with <span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">Influenza</span> A (H1N1) 2009 Monovalent Vaccine and to allow an assessment of benefits and risks.  Appropriate medical treatment and supervision must be available to manage possible <span class="product-label-link" type="condition" conceptid="441202" conceptname="Anaphylaxis">anaphylactic reactions</span> following administration of the vaccine.
</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="s14"></a><a name="section-5.4"></a><p></p>
<h2>5.4 Limitations of Vaccine Effectiveness
</h2>
<p class="First">Vaccination with <span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">Influenza</span> A (H1N1) 2009 Monovalent Vaccine may not protect all individuals.
</p>
</div>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="s15"></a><a name="section-6"></a><p></p>
<h1>6 ADVERSE REACTIONS
</h1>
<p class="First">Novartis’ <span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">Influenza</span> A (H1N1) 2009 Monovalent Vaccine and seasonal trivalent <span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">Influenza</span> Virus Vaccine (FLUVIRIN<span class="Sup">®</span>) are manufactured by the same process.  The data in this section were obtained from clinical studies and postmarketing experience with FLUVIRIN.
</p>
<div class="Section" data-sectionCode="42229-5">
<a name="s16"></a><a name="section-6.1"></a><p></p>
<h2>6.1 Overall Adverse Reaction Profile
</h2>
<p class="First">Serious <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">allergic reactions</span>, including <span class="product-label-link" type="condition" conceptid="441202" conceptname="Anaphylaxis">anaphylactic shock</span>, have been observed in individuals receiving FLUVIRIN during postmarketing surveillance.
</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="s17"></a><a name="section-6.2"></a><p></p>
<h2>6.2 Clinical Trial Experience
</h2>
<p class="First">Adverse event information from clinical trials provides a basis for identifying adverse events that appear to be related to vaccine use and for approximating the rates of these events.  However, because clinical trials are conducted under widely varying conditions, the adverse reaction rates observed in the clinical trials of a vaccine cannot be directly compared to rates in the clinical trials of another vaccine, and may not reflect rates observed in clinical practice.
</p>
<div class="Section" data-sectionCode="42229-5">
<a name="s18"></a><a name="section-6.2.1"></a><p></p>
<p class="First"><span class="Bold">Adult and Geriatric Subjects</span></p>
<p>Safety data were collected in a total of 2768 adult and geriatric subjects (18 years of age and older) who have received FLUVIRIN in 29 clinical studies since 1982.
</p>
<p>In 9 clinical studies since 1997, among 1261 recipients of FLUVIRIN, 745 (59%) were women; 1211 (96%) were White, 23 (2%) Asian, 15 (1%) Black and 12 (1%) other; 370 (29%) of subjects were elderly (≥65 years of age).  All studies have been conducted in the UK, apart from a study run in the US in 2005-2006 where FLUVIRIN was used as a comparator for an unlicensed vaccine.
</p>
<p>After vaccination, the subjects were observed for 30 minutes for <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span> or other immediate reactions.  Subjects were instructed to complete a diary card for three days following immunization (i.e. Day 1 to 4) to collect local and systemic reactions (see <a href="#t1">Tables 1</a> and <a href="#t2">2</a>).  All local and systemic adverse events were considered to be at least possibly related to the vaccine.  Local and systemic reactions mostly began between day 1 and day 2.  The overall adverse events reported in clinical trials since 1998 in at least 5% of the subjects are summarized in <a href="#t3">Table 3</a>.
</p>
<a name="t1"></a><table width="100%">
<caption><span>TABLE 1 Solicited Adverse Events in the First 72-96 Hours after Administration of FLUVIRIN in Adult (18-64 years of age) and Geriatric (≥65 years of age) Subjects.
</span></caption>
<col align="left" width="26.500%">
<col align="left" width="12.529%">
<col align="left" width="11.800%">
<col align="left" width="11.800%">
<col align="left" width="11.800%">
<col align="left" width="11.800%">
<col align="left" width="13.771%">
<thead>
<tr class="First">
<th class="Botrule Lrule Rrule Toprule" align="center" rowspan="3" valign="top"></th>
<th class="Botrule Rrule Toprule" align="center" colspan="2" valign="top">
<span class="Bold">1998-1999</span><span class="Sup">*§</span>
</th>
<th class="Botrule Rrule Toprule" align="center" colspan="2" valign="top">
<span class="Bold">1999-2000</span><span class="Sup">*§</span>
</th>
<th class="Botrule Rrule Toprule" align="center" colspan="2" valign="top">
<span class="Bold">2000-2001</span><span class="Sup">*§</span>
</th>
</tr>
<tr>
<th class="Botrule Rrule" align="center" valign="top"><span class="Bold">18-64 yrs</span></th>
<th class="Botrule Rrule" align="center" valign="top"><span class="Bold">≥ 65 yrs</span></th>
<th class="Botrule Rrule" align="center" valign="top"><span class="Bold">18-64 yrs</span></th>
<th class="Botrule Rrule" align="center" valign="top"><span class="Bold">≥ 65 yrs</span></th>
<th class="Botrule Rrule" align="center" valign="top"><span class="Bold">18-64 yrs</span></th>
<th class="Botrule Rrule" align="center" valign="top"><span class="Bold">≥ 65 yrs</span></th>
</tr>
<tr class="Last">
<th class="Botrule Rrule" align="center" valign="top"><span class="Bold">N = 66</span></th>
<th class="Botrule Rrule" align="center" valign="top"><span class="Bold">N = 44</span></th>
<th class="Botrule Rrule" align="center" valign="top"><span class="Bold">N = 76</span></th>
<th class="Botrule Rrule" align="center" valign="top"><span class="Bold">N = 34</span></th>
<th class="Botrule Rrule" align="center" valign="top"><span class="Bold">N = 75</span></th>
<th class="Botrule Rrule" align="center" valign="top"><span class="Bold">N = 35</span></th>
</tr>
</thead>
<tfoot>
<tr class="First"><td align="left" colspan="7" valign="top"><p class="First Footnote">Results reported to the nearest whole percent; <span class="product-label-link" type="condition" conceptid="437663" conceptname="Fever">Fever</span> defined as &gt;38°C
</p></td></tr>
<tr><td align="left" colspan="7" valign="top"><p class="First Footnote">– not reported
</p></td></tr>
<tr><td align="left" colspan="7" valign="top"><p class="First Footnote">* Solicited adverse events in the first 72 hours after administration of FLUVIRIN
</p></td></tr>
<tr><td align="left" colspan="7" valign="top"><p class="First Footnote">§ Solicited adverse events reported by COSTART preferred term
</p></td></tr>
<tr class="Last"><td align="left" colspan="7" valign="top"><p class="First Footnote">^ Solicited adverse events reported by MEDDRA preferred term
</p></td></tr>
</tfoot>
<tbody>
<tr class="First">
<td class="Lrule Rrule" align="left" valign="top"><span class="Bold">Local Adverse Events</span></td>
<td class="Rrule" align="center" valign="top"></td>
<td class="Rrule" align="center" valign="top"></td>
<td class="Rrule" align="center" valign="top"></td>
<td class="Rrule" align="center" valign="top"></td>
<td class="Rrule" align="center" valign="top"></td>
<td class="Rrule" align="center" valign="top"></td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top">    <span class="product-label-link" type="condition" conceptid="4329041" conceptname="Pain">Pain</span>
</td>
<td class="Rrule" align="center" valign="top">16 (24%)
</td>
<td class="Rrule" align="center" valign="top">4 (9%)
</td>
<td class="Rrule" align="center" valign="top">16 (21%)
</td>
<td class="Rrule" align="center" valign="top">-
</td>
<td class="Rrule" align="center" valign="top">9 (12%)
</td>
<td class="Rrule" align="center" valign="top">-
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top">    <span class="product-label-link" type="condition" conceptid="4041088" conceptname="Mass">Mass</span>
</td>
<td class="Rrule" align="center" valign="top">7 (11%)
</td>
<td class="Rrule" align="center" valign="top">1 (2%)
</td>
<td class="Rrule" align="center" valign="top">4 (5%)
</td>
<td class="Rrule" align="center" valign="top">-
</td>
<td class="Rrule" align="center" valign="top">8 (11%)
</td>
<td class="Rrule" align="center" valign="top">1 (3%)
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top">    <span class="product-label-link" type="condition" conceptid="4053015" conceptname="Inflammation">Inflammation</span>
</td>
<td class="Rrule" align="center" valign="top">5 (8%)
</td>
<td class="Rrule" align="center" valign="top">2 (5%)
</td>
<td class="Rrule" align="center" valign="top">6 (8%)
</td>
<td class="Rrule" align="center" valign="top">-
</td>
<td class="Rrule" align="center" valign="top">7 (9%)
</td>
<td class="Rrule" align="center" valign="top">1 (3%)
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top">    <span class="product-label-link" type="condition" conceptid="4118793" conceptname="Ecchymosis">Ecchymosis</span>
</td>
<td class="Rrule" align="center" valign="top">4 (6%)
</td>
<td class="Rrule" align="center" valign="top">1 (2%)
</td>
<td class="Rrule" align="center" valign="top">3 (4%)
</td>
<td class="Rrule" align="center" valign="top">1 (3%)
</td>
<td class="Rrule" align="center" valign="top">4 (5%)
</td>
<td class="Rrule" align="center" valign="top">-
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top">    <span class="product-label-link" type="condition" conceptid="433595" conceptname="Edema">Edema</span>
</td>
<td class="Rrule" align="center" valign="top">2 (3%)
</td>
<td class="Rrule" align="center" valign="top">1 (2%)
</td>
<td class="Rrule" align="center" valign="top">1 (1%)
</td>
<td class="Rrule" align="center" valign="top">2 (6%)
</td>
<td class="Rrule" align="center" valign="top">3 (4%)
</td>
<td class="Rrule" align="center" valign="top">1 (3%)
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top">    Reaction
</td>
<td class="Rrule" align="center" valign="top">2 (3%)
</td>
<td class="Rrule" align="center" valign="top">-
</td>
<td class="Rrule" align="center" valign="top">2 (3%)
</td>
<td class="Rrule" align="center" valign="top">-
</td>
<td class="Rrule" align="center" valign="top">4 (5%)
</td>
<td class="Rrule" align="center" valign="top">1 (3%)
</td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" align="left" valign="top">    <span class="product-label-link" type="condition" conceptid="437312" conceptname="Bleeding">Hemorrhage</span>
</td>
<td class="Botrule Rrule" align="center" valign="top">-
</td>
<td class="Botrule Rrule" align="center" valign="top">-
</td>
<td class="Botrule Rrule" align="center" valign="top">1 (1%)
</td>
<td class="Botrule Rrule" align="center" valign="top">-
</td>
<td class="Botrule Rrule" align="center" valign="top">-
</td>
<td class="Botrule Rrule" align="center" valign="top">-
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top"><span class="Bold">Systemic Adverse Events</span></td>
<td class="Rrule" align="center" valign="top"></td>
<td class="Rrule" align="center" valign="top"></td>
<td class="Rrule" align="center" valign="top"></td>
<td class="Rrule" align="center" valign="top"></td>
<td class="Rrule" align="center" valign="top"></td>
<td class="Rrule" align="center" valign="top"></td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top">    <span class="product-label-link" type="condition" conceptid="378253" conceptname="Headache">Headache</span>
</td>
<td class="Rrule" align="center" valign="top">7 (11%)
</td>
<td class="Rrule" align="center" valign="top">1 (2%)
</td>
<td class="Rrule" align="center" valign="top">17 (22%)
</td>
<td class="Rrule" align="center" valign="top">3 (9%)
</td>
<td class="Rrule" align="center" valign="top">4 (5%)
</td>
<td class="Rrule" align="center" valign="top">-
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top">    <span class="product-label-link" type="condition" conceptid="4223659" conceptname="Fatigue">Fatigue</span>
</td>
<td class="Rrule" align="center" valign="top">3 (5%)
</td>
<td class="Rrule" align="center" valign="top">2 (5%)
</td>
<td class="Rrule" align="center" valign="top">4 (5%)
</td>
<td class="Rrule" align="center" valign="top">1 (3%)
</td>
<td class="Rrule" align="center" valign="top">3 (4%)
</td>
<td class="Rrule" align="center" valign="top">-
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top">    <span class="product-label-link" type="condition" conceptid="4272240" conceptname="Malaise">Malaise</span>
</td>
<td class="Rrule" align="center" valign="top">2 (3%)
</td>
<td class="Rrule" align="center" valign="top">1 (2%)
</td>
<td class="Rrule" align="center" valign="top">2 (3%)
</td>
<td class="Rrule" align="center" valign="top">1 (3%)
</td>
<td class="Rrule" align="center" valign="top">1 (1%)
</td>
<td class="Rrule" align="center" valign="top">-
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top">    <span class="product-label-link" type="condition" conceptid="442752" conceptname="Muscle pain">Myalgia</span>
</td>
<td class="Rrule" align="center" valign="top">1 (2%)
</td>
<td class="Rrule" align="center" valign="top">-
</td>
<td class="Rrule" align="center" valign="top">2 (3%)
</td>
<td class="Rrule" align="center" valign="top">-
</td>
<td class="Rrule" align="center" valign="top">-
</td>
<td class="Rrule" align="center" valign="top">-
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top">    <span class="product-label-link" type="condition" conceptid="437663" conceptname="Fever">Fever</span>
</td>
<td class="Rrule" align="center" valign="top">1 (2%)
</td>
<td class="Rrule" align="center" valign="top">-
</td>
<td class="Rrule" align="center" valign="top">1 (1%)
</td>
<td class="Rrule" align="center" valign="top">-
</td>
<td class="Rrule" align="center" valign="top">-
</td>
<td class="Rrule" align="center" valign="top">-
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top">    <span class="product-label-link" type="condition" conceptid="77074" conceptname="Joint pain">Arthralgia</span>
</td>
<td class="Rrule" align="center" valign="top">-
</td>
<td class="Rrule" align="center" valign="top">1 (2%)
</td>
<td class="Rrule" align="center" valign="top">-
</td>
<td class="Rrule" align="center" valign="top">1 (3%)
</td>
<td class="Rrule" align="center" valign="top">-
</td>
<td class="Rrule" align="center" valign="top">-
</td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" align="left" valign="top">    <span class="product-label-link" type="condition" conceptid="138565" conceptname="Hyperhidrosis">Sweating</span>
</td>
<td class="Botrule Rrule" align="center" valign="top">-
</td>
<td class="Botrule Rrule" align="center" valign="top">-
</td>
<td class="Botrule Rrule" align="center" valign="top">3 (4%)
</td>
<td class="Botrule Rrule" align="center" valign="top">-
</td>
<td class="Botrule Rrule" align="center" valign="top">1 (1%)
</td>
<td class="Botrule Rrule" align="center" valign="top">1 (3%)
</td>
</tr>
<tr>
<td class="Botrule" align="left" valign="top"> 
</td>
<td class="Botrule" align="center" valign="top"></td>
<td class="Botrule" align="center" valign="top"></td>
<td class="Botrule" align="center" valign="top"></td>
<td class="Botrule" align="center" valign="top"></td>
<td class="Botrule" align="center" valign="top"></td>
<td class="Botrule" align="center" valign="top"></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" align="left" rowspan="3" valign="top"></td>
<td class="Botrule Rrule" align="center" colspan="2" valign="top">
<span class="Bold">2001-2002</span><span class="Sup">*^</span>
</td>
<td class="Botrule Rrule" align="center" colspan="2" valign="top">
<span class="Bold">2002-2003</span><span class="Sup">*^</span>
</td>
<td class="Botrule Rrule" align="center" colspan="2" valign="top">
<span class="Bold">2004-2005*</span><span class="Sup">^</span>
</td>
</tr>
<tr>
<td class="Botrule Rrule" align="center" valign="top"><span class="Bold">18-64 yrs</span></td>
<td class="Botrule Rrule" align="center" valign="top"><span class="Bold">≥ 65 yrs</span></td>
<td class="Botrule Rrule" align="center" valign="top"><span class="Bold">18-64 yrs</span></td>
<td class="Botrule Rrule" align="center" valign="top"><span class="Bold">≥ 65 yrs</span></td>
<td class="Botrule Rrule" align="center" valign="top"><span class="Bold">18-64 yrs</span></td>
<td class="Botrule Rrule" align="center" valign="top"><span class="Bold">≥ 65 yrs</span></td>
</tr>
<tr>
<td class="Botrule Rrule" align="center" valign="top"><span class="Bold">N = 75</span></td>
<td class="Botrule Rrule" align="center" valign="top"><span class="Bold">N = 35</span></td>
<td class="Botrule Rrule" align="center" valign="top"><span class="Bold">N = 107</span></td>
<td class="Botrule Rrule" align="center" valign="top"><span class="Bold">N = 88</span></td>
<td class="Botrule Rrule" align="center" valign="top"><span class="Bold">N = 74</span></td>
<td class="Botrule Rrule" align="center" valign="top"><span class="Bold">N = 61</span></td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top"><span class="Bold">Local Adverse Events</span></td>
<td class="Rrule" align="center" valign="top"></td>
<td class="Rrule" align="center" valign="top"></td>
<td class="Rrule" align="center" valign="top"></td>
<td class="Rrule" align="center" valign="top"></td>
<td class="Rrule" align="center" valign="top"></td>
<td class="Rrule" align="center" valign="top"></td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top">    <span class="product-label-link" type="condition" conceptid="4329041" conceptname="Pain">Pain</span>
</td>
<td class="Rrule" align="center" valign="top">12 (16%)
</td>
<td class="Rrule" align="center" valign="top">1 (3%)
</td>
<td class="Rrule" align="center" valign="top">14 (13%)
</td>
<td class="Rrule" align="center" valign="top">7 (8%)
</td>
<td class="Rrule" align="center" valign="top">15 (20%)
</td>
<td class="Rrule" align="center" valign="top">9 (15%)
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top">    <span class="product-label-link" type="condition" conceptid="4041088" conceptname="Mass">Mass</span>
</td>
<td class="Rrule" align="center" valign="top">4 (5%)
</td>
<td class="Rrule" align="center" valign="top">1 (3%)
</td>
<td class="Rrule" align="center" valign="top">-
</td>
<td class="Rrule" align="center" valign="top">-
</td>
<td class="Rrule" align="center" valign="top">-
</td>
<td class="Rrule" align="center" valign="top">-
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top">    <span class="product-label-link" type="condition" conceptid="4118793" conceptname="Ecchymosis">Ecchymosis</span>
</td>
<td class="Rrule" align="center" valign="top">2 (3%)
</td>
<td class="Rrule" align="center" valign="top">-
</td>
<td class="Rrule" align="center" valign="top">3 (3%)
</td>
<td class="Rrule" align="center" valign="top">3 (3%)
</td>
<td class="Rrule" align="center" valign="top">2 (3%)
</td>
<td class="Rrule" align="center" valign="top">1 (2%)
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top">    <span class="product-label-link" type="condition" conceptid="433595" conceptname="Edema">Edema</span>
</td>
<td class="Rrule" align="center" valign="top">2 (3%)
</td>
<td class="Rrule" align="center" valign="top">1 (3%)
</td>
<td class="Rrule" align="center" valign="top">6 (6%)
</td>
<td class="Rrule" align="center" valign="top">2 (2%)
</td>
<td class="Rrule" align="center" valign="top">-
</td>
<td class="Rrule" align="center" valign="top">-
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top">    <span class="product-label-link" type="condition" conceptid="137193" conceptname="Erythema">Erythema</span>
</td>
<td class="Rrule" align="center" valign="top">5 (7%)
</td>
<td class="Rrule" align="center" valign="top">-
</td>
<td class="Rrule" align="center" valign="top">11 (10%)
</td>
<td class="Rrule" align="center" valign="top">5 (6%)
</td>
<td class="Rrule" align="center" valign="top">16 (22%)
</td>
<td class="Rrule" align="center" valign="top">5 (8%)
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top">    <span class="product-label-link" type="condition" conceptid="4275722" conceptname="Swelling">Swelling</span>
</td>
<td class="Rrule" align="center" valign="top">-
</td>
<td class="Rrule" align="center" valign="top">-
</td>
<td class="Rrule" align="center" valign="top">-
</td>
<td class="Rrule" align="center" valign="top">-
</td>
<td class="Rrule" align="center" valign="top">11 (15%)
</td>
<td class="Rrule" align="center" valign="top">4 (7%)
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top">    Reaction
</td>
<td class="Rrule" align="center" valign="top">-
</td>
<td class="Rrule" align="center" valign="top">-
</td>
<td class="Rrule" align="center" valign="top">2 (2%)
</td>
<td class="Rrule" align="center" valign="top">-
</td>
<td class="Rrule" align="center" valign="top">-
</td>
<td class="Rrule" align="center" valign="top">-
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top">    <span class="product-label-link" type="condition" conceptid="4165876" conceptname="Induration">Induration</span>
</td>
<td class="Rrule" align="center" valign="top">-
</td>
<td class="Rrule" align="center" valign="top">-
</td>
<td class="Rrule" align="center" valign="top">14 (13%)
</td>
<td class="Rrule" align="center" valign="top">3 (3%)
</td>
<td class="Rrule" align="center" valign="top">11 (15%)
</td>
<td class="Rrule" align="center" valign="top">1 (2%)
</td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" align="left" valign="top">    <span class="product-label-link" type="condition" conceptid="4169287" conceptname="Itching of skin">Pruritus</span>
</td>
<td class="Botrule Rrule" align="center" valign="top">-
</td>
<td class="Botrule Rrule" align="center" valign="top">-
</td>
<td class="Botrule Rrule" align="center" valign="top">1 (1%)
</td>
<td class="Botrule Rrule" align="center" valign="top">-
</td>
<td class="Botrule Rrule" align="center" valign="top">-
</td>
<td class="Botrule Rrule" align="center" valign="top">-
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top"><span class="Bold">Systemic Adverse Events</span></td>
<td class="Rrule" align="center" valign="top"></td>
<td class="Rrule" align="center" valign="top"></td>
<td class="Rrule" align="center" valign="top"></td>
<td class="Rrule" align="center" valign="top"></td>
<td class="Rrule" align="center" valign="top"></td>
<td class="Rrule" align="center" valign="top"></td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top">    <span class="product-label-link" type="condition" conceptid="378253" conceptname="Headache">Headache</span>
</td>
<td class="Rrule" align="center" valign="top">8 (11%)
</td>
<td class="Rrule" align="center" valign="top">1 (3%)
</td>
<td class="Rrule" align="center" valign="top">12 (11%)
</td>
<td class="Rrule" align="center" valign="top">9 (10%)
</td>
<td class="Rrule" align="center" valign="top">14 (19%)
</td>
<td class="Rrule" align="center" valign="top">3 (5%)
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top">    <span class="product-label-link" type="condition" conceptid="4223659" conceptname="Fatigue">Fatigue</span>
</td>
<td class="Rrule" align="center" valign="top">1 (1%)
</td>
<td class="Rrule" align="center" valign="top">1 (3%)
</td>
<td class="Rrule" align="center" valign="top">-
</td>
<td class="Rrule" align="center" valign="top">-
</td>
<td class="Rrule" align="center" valign="top">5 (7%)
</td>
<td class="Rrule" align="center" valign="top">2 (3%)
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top">    <span class="product-label-link" type="condition" conceptid="4272240" conceptname="Malaise">Malaise</span>
</td>
<td class="Rrule" align="center" valign="top">3 (4%)
</td>
<td class="Rrule" align="center" valign="top">-
</td>
<td class="Rrule" align="center" valign="top">3 (3%)
</td>
<td class="Rrule" align="center" valign="top">4 (5%)
</td>
<td class="Rrule" align="center" valign="top">1 (1%)
</td>
<td class="Rrule" align="center" valign="top">1 (2%)
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top">    <span class="product-label-link" type="condition" conceptid="442752" conceptname="Muscle pain">Myalgia</span>
</td>
<td class="Rrule" align="center" valign="top">3 (4%)
</td>
<td class="Rrule" align="center" valign="top">-
</td>
<td class="Rrule" align="center" valign="top">5 (5%)
</td>
<td class="Rrule" align="center" valign="top">3 (3%)
</td>
<td class="Rrule" align="center" valign="top">8 (11%)
</td>
<td class="Rrule" align="center" valign="top">1 (2%)
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top">    <span class="product-label-link" type="condition" conceptid="437663" conceptname="Fever">Fever</span>
</td>
<td class="Rrule" align="center" valign="top">-
</td>
<td class="Rrule" align="center" valign="top">-
</td>
<td class="Rrule" align="center" valign="top">-
</td>
<td class="Rrule" align="center" valign="top">1 (1%)
</td>
<td class="Rrule" align="center" valign="top">-
</td>
<td class="Rrule" align="center" valign="top">-
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top">    <span class="product-label-link" type="condition" conceptid="77074" conceptname="Joint pain">Arthralgia</span>
</td>
<td class="Rrule" align="center" valign="top">-
</td>
<td class="Rrule" align="center" valign="top">-
</td>
<td class="Rrule" align="center" valign="top">2 (2%)
</td>
<td class="Rrule" align="center" valign="top">-
</td>
<td class="Rrule" align="center" valign="top">1 (1%)
</td>
<td class="Rrule" align="center" valign="top">-
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top">    <span class="product-label-link" type="condition" conceptid="138565" conceptname="Hyperhidrosis">Sweating</span>
</td>
<td class="Rrule" align="center" valign="top">3 (4%)
</td>
<td class="Rrule" align="center" valign="top">1 (3%)
</td>
<td class="Rrule" align="center" valign="top">-
</td>
<td class="Rrule" align="center" valign="top">2 (2%)
</td>
<td class="Rrule" align="center" valign="top">-
</td>
<td class="Rrule" align="center" valign="top">-
</td>
</tr>
<tr class="Last">
<td class="Botrule Lrule Rrule" align="left" valign="top">    <span class="product-label-link" type="condition" conceptid="4190045" conceptname="Rigor">Shivering</span>
</td>
<td class="Botrule Rrule" align="center" valign="top">-
</td>
<td class="Botrule Rrule" align="center" valign="top">-
</td>
<td class="Botrule Rrule" align="center" valign="top">-
</td>
<td class="Botrule Rrule" align="center" valign="top">1 (1%)
</td>
<td class="Botrule Rrule" align="center" valign="top">-
</td>
<td class="Botrule Rrule" align="center" valign="top">-
</td>
</tr>
</tbody>
</table>
<a name="t2"></a><table width="100%">
<caption><span>TABLE 2 Solicited Adverse Events in the First 72 Hours after Administration of FLUVIRIN in Adult Subjects (18-49 years of age).
</span></caption>
<col align="left" width="56.650%">
<col align="left" width="43.350%">
<thead>
<tr class="First">
<th class="Botrule Lrule Rrule Toprule" align="left" rowspan="3" valign="top"></th>
<th class="Rrule Toprule" align="center" valign="top">2005-2006 US Trial
</th>
</tr>
<tr><th class="Rrule" align="center" valign="top">FLUVIRIN
</th></tr>
<tr class="Last"><th class="Botrule Rrule" align="center" valign="top">N = 304
</th></tr>
</thead>
<tfoot>
<tr class="First"><td align="left" colspan="2" valign="top"><p class="First Footnote">Results reported to the nearest whole percent
</p></td></tr>
<tr class="Last"><td align="left" colspan="2" valign="top"><p class="First Footnote">– not reported
</p></td></tr>
</tfoot>
<tbody>
<tr class="First">
<td class="Lrule Rrule" align="left" valign="top"><span class="Bold">Local Adverse Events</span></td>
<td class="Rrule" align="center" valign="top"></td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top">    <span class="product-label-link" type="condition" conceptid="4329041" conceptname="Pain">Pain</span>
</td>
<td class="Rrule" align="center" valign="top">168 (55%)
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top">    <span class="product-label-link" type="condition" conceptid="137193" conceptname="Erythema">Erythema</span>
</td>
<td class="Rrule" align="center" valign="top">48 (16%)
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top">    <span class="product-label-link" type="condition" conceptid="4118793" conceptname="Ecchymosis">Ecchymosis</span>
</td>
<td class="Rrule" align="center" valign="top">22 (7%)
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top">    <span class="product-label-link" type="condition" conceptid="4165876" conceptname="Induration">Induration</span>
</td>
<td class="Rrule" align="center" valign="top">19 (6%)
</td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" align="left" valign="top">    <span class="product-label-link" type="condition" conceptid="4275722" conceptname="Swelling">Swelling</span>
</td>
<td class="Botrule Rrule" align="center" valign="top">16 (5%)
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top"><span class="Bold">Systemic Adverse Events</span></td>
<td class="Rrule" align="center" valign="top"></td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top">    <span class="product-label-link" type="condition" conceptid="378253" conceptname="Headache">Headache</span>
</td>
<td class="Rrule" align="center" valign="top">91 (30%)
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top">    <span class="product-label-link" type="condition" conceptid="442752" conceptname="Muscle pain">Myalgia</span>
</td>
<td class="Rrule" align="center" valign="top">64 (21%)
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top">    <span class="product-label-link" type="condition" conceptid="4272240" conceptname="Malaise">Malaise</span>
</td>
<td class="Rrule" align="center" valign="top">58 (19%)
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top">    <span class="product-label-link" type="condition" conceptid="4223659" conceptname="Fatigue">Fatigue</span>
</td>
<td class="Rrule" align="center" valign="top">56 (18%)
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top">    <span class="product-label-link" type="condition" conceptid="26711" conceptname="Chronic pharyngitis">Sore throat</span>
</td>
<td class="Rrule" align="center" valign="top">23 (8%)
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top">    <span class="product-label-link" type="condition" conceptid="4190045" conceptname="Rigor">Chills</span>
</td>
<td class="Rrule" align="center" valign="top">22 (7%)
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top">    <span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">Nausea</span>
</td>
<td class="Rrule" align="center" valign="top">21 (7%)
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top">    <span class="product-label-link" type="condition" conceptid="77074" conceptname="Joint pain">Arthralgia</span>
</td>
<td class="Rrule" align="center" valign="top">20 (7%)
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top">    <span class="product-label-link" type="condition" conceptid="138565" conceptname="Hyperhidrosis">Sweating</span>
</td>
<td class="Rrule" align="center" valign="top">17 (6%)
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top">    <span class="product-label-link" type="condition" conceptid="254761" conceptname="Cough">Cough</span>
</td>
<td class="Rrule" align="center" valign="top">18 (6%)
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top">    <span class="product-label-link" type="condition" conceptid="314754" conceptname="Wheezing">Wheezing</span>
</td>
<td class="Rrule" align="center" valign="top">4 (1%)
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top">    <span class="product-label-link" type="condition" conceptid="4034235" conceptname="Tight chest">Chest tightness</span>
</td>
<td class="Rrule" align="center" valign="top">4 (1%)
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top">    Other difficulties breathing
</td>
<td class="Rrule" align="center" valign="top">3 (1%)
</td>
</tr>
<tr class="Last">
<td class="Botrule Lrule Rrule" align="left" valign="top">    Facial <span class="product-label-link" type="condition" conceptid="433595" conceptname="Edema">edema</span>
</td>
<td class="Botrule Rrule" align="center" valign="top">-
</td>
</tr>
</tbody>
</table>
<a name="t3"></a><table width="100%">
<caption><span>TABLE 3 Adverse Events Reported by at least 5% of Subjects in Clinical Trials since 1998
</span></caption>
<col align="left" width="26.494%">
<col align="left" width="11.986%">
<col align="left" width="10%">
<col align="left" width="12.253%">
<col align="left" width="11.631%">
<col align="left" width="10%">
<col align="left" width="11.675%">
<col align="left" width="11.797%">
<col align="left" width="13.764%">
<thead>
<tr class="First">
<th class="Botrule Lrule Rrule Toprule" align="left" rowspan="3" valign="top"></th>
<th class="Botrule Rrule Toprule" align="center" colspan="3" valign="top">1998-1999<span class="Sup">§</span>
</th>
<th class="Botrule Rrule Toprule" align="center" colspan="3" valign="top">1999-2000<span class="Sup">§</span>
</th>
<th class="Botrule Rrule Toprule" align="center" colspan="2" valign="top">2000-2001<span class="Sup">§</span>
</th>
</tr>
<tr>
<th class="Botrule Rrule" align="center" valign="top">18-64 yrs
</th>
<th class="Botrule Rrule" align="center" colspan="2" valign="top">≥ 65 yrs
</th>
<th class="Botrule Rrule" align="center" valign="top">18-64 yrs
</th>
<th class="Botrule Rrule" align="center" colspan="2" valign="top">≥ 65 yrs
</th>
<th class="Botrule Rrule" align="center" valign="top">18-64 yrs
</th>
<th class="Botrule Rrule" align="center" valign="top">≥ 65 yrs
</th>
</tr>
<tr class="Last">
<th class="Botrule Rrule" align="center" valign="top">N = 66
</th>
<th class="Botrule Rrule" align="center" colspan="2" valign="top">N = 44
</th>
<th class="Botrule Rrule" align="center" valign="top">N = 76
</th>
<th class="Botrule Rrule" align="center" colspan="2" valign="top">N = 34
</th>
<th class="Botrule Rrule" align="center" valign="top">N = 75
</th>
<th class="Botrule Rrule" align="center" valign="top">N = 35
</th>
</tr>
</thead>
<tfoot>
<tr class="First"><td align="left" colspan="9" valign="top"><p class="First Footnote">Results reported to the nearest whole percent; <span class="product-label-link" type="condition" conceptid="437663" conceptname="Fever">Fever</span> defined as &gt;38°C
</p></td></tr>
<tr><td align="left" colspan="9" valign="top"><p class="First Footnote">– not reaching the cut-off of 5%
</p></td></tr>
<tr><td align="left" colspan="9" valign="top"><p class="First Footnote">§ Solicited adverse events reported by COSTART preferred term
</p></td></tr>
<tr class="Last"><td align="left" colspan="9" valign="top"><p class="First Footnote">^ Solicited adverse events reported by MEDDRA preferred term
</p></td></tr>
</tfoot>
<tbody>
<tr class="First">
<td class="Lrule Rrule" align="left" valign="top"><span class="Bold">Adverse Events</span></td>
<td class="Rrule" align="center" valign="top"></td>
<td class="Rrule" align="center" colspan="2" valign="top"></td>
<td class="Rrule" align="center" valign="top"></td>
<td class="Rrule" align="center" colspan="2" valign="top"></td>
<td class="Rrule" align="center" valign="top"></td>
<td class="Rrule" align="center" valign="top"></td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top"><span class="product-label-link" type="condition" conceptid="4223659" conceptname="Fatigue">Fatigue</span>
</td>
<td class="Rrule" align="center" valign="top">8 (12%)
</td>
<td class="Rrule" align="center" colspan="2" valign="top">2 (5%)
</td>
<td class="Rrule" align="center" valign="top">8 (11%)
</td>
<td class="Rrule" align="center" colspan="2" valign="top">2 (6%)
</td>
<td class="Rrule" align="center" valign="top">5 (7%)
</td>
<td class="Rrule" align="center" valign="top">-
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top"><span class="product-label-link" type="condition" conceptid="134736" conceptname="Backache">Back pain</span>
</td>
<td class="Rrule" align="center" valign="top">4 (6%)
</td>
<td class="Rrule" align="center" colspan="2" valign="top">3 (7%)
</td>
<td class="Rrule" align="center" valign="top">-
</td>
<td class="Rrule" align="center" colspan="2" valign="top">-
</td>
<td class="Rrule" align="center" valign="top">-
</td>
<td class="Rrule" align="center" valign="top">-
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top"><span class="product-label-link" type="condition" conceptid="254761" conceptname="Cough">Cough increased</span>
</td>
<td class="Rrule" align="center" valign="top">2 (3%)
</td>
<td class="Rrule" align="center" colspan="2" valign="top">2 (5%)
</td>
<td class="Rrule" align="center" valign="top">-
</td>
<td class="Rrule" align="center" colspan="2" valign="top">-
</td>
<td class="Rrule" align="center" valign="top">-
</td>
<td class="Rrule" align="center" valign="top">-
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top"><span class="product-label-link" type="condition" conceptid="4118793" conceptname="Ecchymosis">Ecchymosis</span>
</td>
<td class="Rrule" align="center" valign="top">4 (6%)
</td>
<td class="Rrule" align="center" colspan="2" valign="top">1 (2%)
</td>
<td class="Rrule" align="center" valign="top">4 (5%)
</td>
<td class="Rrule" align="center" colspan="2" valign="top">1 (3%)
</td>
<td class="Rrule" align="center" valign="top">5 (7%)
</td>
<td class="Rrule" align="center" valign="top">-
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top"><span class="product-label-link" type="condition" conceptid="437663" conceptname="Fever">Fever</span>
</td>
<td class="Rrule" align="center" valign="top">3 (5%)
</td>
<td class="Rrule" align="center" colspan="2" valign="top">-
</td>
<td class="Rrule" align="center" valign="top">-
</td>
<td class="Rrule" align="center" colspan="2" valign="top">-
</td>
<td class="Rrule" align="center" valign="top">-
</td>
<td class="Rrule" align="center" valign="top">-
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top"><span class="product-label-link" type="condition" conceptid="378253" conceptname="Headache">Headache</span>
</td>
<td class="Rrule" align="center" valign="top">12 (18%)
</td>
<td class="Rrule" align="center" colspan="2" valign="top">5 (11%)
</td>
<td class="Rrule" align="center" valign="top">22 (29%)
</td>
<td class="Rrule" align="center" colspan="2" valign="top">5 (15%)
</td>
<td class="Rrule" align="center" valign="top">14 (19%)
</td>
<td class="Rrule" align="center" valign="top">2 (6%)
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top"><span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">Infection</span>
</td>
<td class="Rrule" align="center" valign="top">3 (5%)
</td>
<td class="Rrule" align="center" colspan="2" valign="top">2 (5%)
</td>
<td class="Rrule" align="center" valign="top">-
</td>
<td class="Rrule" align="center" colspan="2" valign="top">-
</td>
<td class="Rrule" align="center" valign="top">-
</td>
<td class="Rrule" align="center" valign="top">-
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top"><span class="product-label-link" type="condition" conceptid="4272240" conceptname="Malaise">Malaise</span>
</td>
<td class="Rrule" align="center" valign="top">4 (6%)
</td>
<td class="Rrule" align="center" colspan="2" valign="top">4 (9%)
</td>
<td class="Rrule" align="center" valign="top">4 (5%)
</td>
<td class="Rrule" align="center" colspan="2" valign="top">1 (3%)
</td>
<td class="Rrule" align="center" valign="top">-
</td>
<td class="Rrule" align="center" valign="top">-
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top"><span class="product-label-link" type="condition" conceptid="318736" conceptname="Migraine">Migraine</span>
</td>
<td class="Rrule" align="center" valign="top">4 (6%)
</td>
<td class="Rrule" align="center" colspan="2" valign="top">1 (2%)
</td>
<td class="Rrule" align="center" valign="top">-
</td>
<td class="Rrule" align="center" colspan="2" valign="top">-
</td>
<td class="Rrule" align="center" valign="top">-
</td>
<td class="Rrule" align="center" valign="top">-
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top"><span class="product-label-link" type="condition" conceptid="442752" conceptname="Muscle pain">Myalgia</span>
</td>
<td class="Rrule" align="center" valign="top">4 (6%)
</td>
<td class="Rrule" align="center" colspan="2" valign="top">1 (2%)
</td>
<td class="Rrule" align="center" valign="top">-
</td>
<td class="Rrule" align="center" colspan="2" valign="top">-
</td>
<td class="Rrule" align="center" valign="top">-
</td>
<td class="Rrule" align="center" valign="top">-
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top"><span class="product-label-link" type="condition" conceptid="138565" conceptname="Hyperhidrosis">Sweating</span>
</td>
<td class="Rrule" align="center" valign="top">5 (8%)
</td>
<td class="Rrule" align="center" colspan="2" valign="top">1 (2%)
</td>
<td class="Rrule" align="center" valign="top">-
</td>
<td class="Rrule" align="center" colspan="2" valign="top">-
</td>
<td class="Rrule" align="center" valign="top">-
</td>
<td class="Rrule" align="center" valign="top">-
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top"><span class="product-label-link" type="condition" conceptid="4320791" conceptname="Rhinitis">Rhinitis</span>
</td>
<td class="Rrule" align="center" valign="top">3 (5%)
</td>
<td class="Rrule" align="center" colspan="2" valign="top">1 (2%)
</td>
<td class="Rrule" align="center" valign="top">-
</td>
<td class="Rrule" align="center" colspan="2" valign="top">-
</td>
<td class="Rrule" align="center" valign="top">5 (7%)
</td>
<td class="Rrule" align="center" valign="top">2 (6%)
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top">Pharingitis
</td>
<td class="Rrule" align="center" valign="top">6 (9%)
</td>
<td class="Rrule" align="center" colspan="2" valign="top">1 (2%)
</td>
<td class="Rrule" align="center" valign="top">10 (13%)
</td>
<td class="Rrule" align="center" colspan="2" valign="top">-
</td>
<td class="Rrule" align="center" valign="top">6 (8%)
</td>
<td class="Rrule" align="center" valign="top">-
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top"><span class="product-label-link" type="condition" conceptid="77074" conceptname="Joint pain">Arthralgia</span>
</td>
<td class="Rrule" align="center" valign="top">-
</td>
<td class="Rrule" align="center" colspan="2" valign="top">-
</td>
<td class="Rrule" align="center" valign="top">-
</td>
<td class="Rrule" align="center" colspan="2" valign="top">2 (6%)
</td>
<td class="Rrule" align="center" valign="top">-
</td>
<td class="Rrule" align="center" valign="top">-
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top"><span class="product-label-link" type="condition" conceptid="4316207" conceptname="Injection site pain">Injection site pain</span>
</td>
<td class="Rrule" align="center" valign="top">16 (24%)
</td>
<td class="Rrule" align="center" colspan="2" valign="top">4 (9%)
</td>
<td class="Rrule" align="center" valign="top">16 (21%)
</td>
<td class="Rrule" align="center" colspan="2" valign="top">-
</td>
<td class="Rrule" align="center" valign="top">9 (12%)
</td>
<td class="Rrule" align="center" valign="top">-
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top"><span class="product-label-link" type="condition" conceptid="4316205" conceptname="Injection site hemorrhage">Injection site ecchymosis</span>
</td>
<td class="Rrule" align="center" valign="top">4 (6%)
</td>
<td class="Rrule" align="center" colspan="2" valign="top">1 (2%)
</td>
<td class="Rrule" align="center" valign="top">-
</td>
<td class="Rrule" align="center" colspan="2" valign="top">-
</td>
<td class="Rrule" align="center" valign="top">4 (5%)
</td>
<td class="Rrule" align="center" valign="top">-
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top"><span class="product-label-link" type="condition" conceptid="4317274" conceptname="Injection site mass">Injection site mass</span>
</td>
<td class="Rrule" align="center" valign="top">7 (11%)
</td>
<td class="Rrule" align="center" colspan="2" valign="top">1 (2%)
</td>
<td class="Rrule" align="center" valign="top">4 (5%)
</td>
<td class="Rrule" align="center" colspan="2" valign="top">-
</td>
<td class="Rrule" align="center" valign="top">8 (11%)
</td>
<td class="Rrule" align="center" valign="top">1 (3%)
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top"><span class="product-label-link" type="condition" conceptid="4319319" conceptname="Injection site edema">Injection site edema</span>
</td>
<td class="Rrule" align="center" valign="top">-
</td>
<td class="Rrule" align="center" colspan="2" valign="top">-
</td>
<td class="Rrule" align="center" valign="top">1 (1%)
</td>
<td class="Rrule" align="center" colspan="2" valign="top">2 (6%)
</td>
<td class="Rrule" align="center" valign="top">-
</td>
<td class="Rrule" align="center" valign="top">-
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top"><span class="product-label-link" type="condition" conceptid="4319318" conceptname="Injection site inflammation">Injection site inflammation</span>
</td>
<td class="Rrule" align="center" valign="top">5 (8%)
</td>
<td class="Rrule" align="center" colspan="2" valign="top">2 (5%)
</td>
<td class="Rrule" align="center" valign="top">6 (8%)
</td>
<td class="Rrule" align="center" colspan="2" valign="top">-
</td>
<td class="Rrule" align="center" valign="top">7 (9%)
</td>
<td class="Rrule" align="center" valign="top">1 (3%)
</td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" align="left" valign="top"><span class="product-label-link" type="condition" conceptid="4316202" conceptname="Injection site reaction">Injection site reaction</span>
</td>
<td class="Botrule Rrule" align="center" valign="top">-
</td>
<td class="Botrule Rrule" align="center" colspan="2" valign="top">-
</td>
<td class="Botrule Rrule" align="center" valign="top">-
</td>
<td class="Botrule Rrule" align="center" colspan="2" valign="top">-
</td>
<td class="Botrule Rrule" align="center" valign="top">4 (5%)
</td>
<td class="Botrule Rrule" align="center" valign="top">1 (3%)
</td>
</tr>
<tr>
<td class="Botrule" align="left" valign="top"> 
</td>
<td class="Botrule" align="center" valign="top"></td>
<td class="Botrule" align="center" colspan="2" valign="top"></td>
<td class="Botrule" align="center" valign="top"></td>
<td class="Botrule" align="center" colspan="2" valign="top"></td>
<td class="Botrule" align="center" valign="top"></td>
<td class="Botrule" align="center" valign="top"></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" align="left" rowspan="3" valign="top"></td>
<td class="Botrule Rrule" align="center" colspan="3" valign="top">
<span class="Bold">2001-2002</span><span class="Sup">^</span>
</td>
<td class="Botrule Rrule" align="center" colspan="3" valign="top">
<span class="Bold">2002-2003</span><span class="Sup">^</span>
</td>
<td class="Botrule Rrule" align="center" colspan="2" valign="top">
<span class="Bold">2004-2005</span><span class="Sup">^</span>
</td>
</tr>
<tr>
<td class="Botrule Rrule" align="center" colspan="2" valign="top"><span class="Bold">18-64 yrs</span></td>
<td class="Botrule Rrule" align="center" valign="top"><span class="Bold">≥ 65 yrs</span></td>
<td class="Botrule Rrule" align="center" colspan="2" valign="top"><span class="Bold">18-64 yrs</span></td>
<td class="Botrule Rrule" align="center" valign="top"><span class="Bold">≥ 65 yrs</span></td>
<td class="Botrule Rrule" align="center" valign="top"><span class="Bold">18-64 yrs</span></td>
<td class="Botrule Rrule" align="center" valign="top"><span class="Bold">≥ 65 yrs</span></td>
</tr>
<tr>
<td class="Botrule Rrule" align="center" colspan="2" valign="top"><span class="Bold">N = 75</span></td>
<td class="Botrule Rrule" align="center" valign="top"><span class="Bold">N = 35</span></td>
<td class="Botrule Rrule" align="center" colspan="2" valign="top"><span class="Bold">N = 107</span></td>
<td class="Botrule Rrule" align="center" valign="top"><span class="Bold">N = 88</span></td>
<td class="Botrule Rrule" align="center" valign="top"><span class="Bold">N = 74</span></td>
<td class="Botrule Rrule" align="center" valign="top"><span class="Bold">N = 61</span></td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top"><span class="Bold">Adverse Events</span></td>
<td class="Rrule" align="center" colspan="2" valign="top"></td>
<td class="Rrule" align="center" valign="top"></td>
<td class="Rrule" align="center" colspan="2" valign="top"></td>
<td class="Rrule" align="center" valign="top"></td>
<td class="Rrule" align="center" valign="top"></td>
<td class="Rrule" align="center" valign="top"></td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top"><span class="product-label-link" type="condition" conceptid="4223659" conceptname="Fatigue">Fatigue</span>
</td>
<td class="Rrule" align="center" colspan="2" valign="top">5 (7%)
</td>
<td class="Rrule" align="center" valign="top">4 (11%)
</td>
<td class="Rrule" align="center" colspan="2" valign="top">11 (10%)
</td>
<td class="Rrule" align="center" valign="top">8 (9%)
</td>
<td class="Rrule" align="center" valign="top">4 (5%)
</td>
<td class="Rrule" align="center" valign="top">2 (3%)
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top"><span class="product-label-link" type="condition" conceptid="316866" conceptname="Hypertensive disorder">Hypertension</span>
</td>
<td class="Rrule" align="center" colspan="2" valign="top">-
</td>
<td class="Rrule" align="center" valign="top">-
</td>
<td class="Rrule" align="center" colspan="2" valign="top">1 (1%)
</td>
<td class="Rrule" align="center" valign="top">4 (5%)
</td>
<td class="Rrule" align="center" valign="top">-
</td>
<td class="Rrule" align="center" valign="top">-
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top">Rinorrhea
</td>
<td class="Rrule" align="center" colspan="2" valign="top">-
</td>
<td class="Rrule" align="center" valign="top">-
</td>
<td class="Rrule" align="center" colspan="2" valign="top">2 (2%)
</td>
<td class="Rrule" align="center" valign="top">5 (6%)
</td>
<td class="Rrule" align="center" valign="top">-
</td>
<td class="Rrule" align="center" valign="top">-
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top"><span class="product-label-link" type="condition" conceptid="378253" conceptname="Headache">Headache</span>
</td>
<td class="Rrule" align="center" colspan="2" valign="top">20 (27%)
</td>
<td class="Rrule" align="center" valign="top">2 (6%)
</td>
<td class="Rrule" align="center" colspan="2" valign="top">35 (33%)
</td>
<td class="Rrule" align="center" valign="top">18 (20%)
</td>
<td class="Rrule" align="center" valign="top">12 (16%)
</td>
<td class="Rrule" align="center" valign="top">1 (2%)
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top"><span class="product-label-link" type="condition" conceptid="4272240" conceptname="Malaise">Malaise</span>
</td>
<td class="Rrule" align="center" colspan="2" valign="top">6 (8%)
</td>
<td class="Rrule" align="center" valign="top">1 (3%)
</td>
<td class="Rrule" align="center" colspan="2" valign="top">13 (12%)
</td>
<td class="Rrule" align="center" valign="top">8 (9%)
</td>
<td class="Rrule" align="center" valign="top">-
</td>
<td class="Rrule" align="center" valign="top">-
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top"><span class="product-label-link" type="condition" conceptid="442752" conceptname="Muscle pain">Myalgia</span>
</td>
<td class="Rrule" align="center" colspan="2" valign="top">4 (5%)
</td>
<td class="Rrule" align="center" valign="top">1 (3%)
</td>
<td class="Rrule" align="center" colspan="2" valign="top">10 (9%)
</td>
<td class="Rrule" align="center" valign="top">4 (5%)
</td>
<td class="Rrule" align="center" valign="top">-
</td>
<td class="Rrule" align="center" valign="top">-
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top"><span class="product-label-link" type="condition" conceptid="138565" conceptname="Hyperhidrosis">Sweating</span>
</td>
<td class="Rrule" align="center" colspan="2" valign="top">3 (4%)
</td>
<td class="Rrule" align="center" valign="top">3 (9%)
</td>
<td class="Rrule" align="center" colspan="2" valign="top">2 (2%)
</td>
<td class="Rrule" align="center" valign="top">5 (6%)
</td>
<td class="Rrule" align="center" valign="top">-
</td>
<td class="Rrule" align="center" valign="top">-
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top"><span class="product-label-link" type="condition" conceptid="4320791" conceptname="Rhinitis">Rhinitis</span>
</td>
<td class="Rrule" align="center" colspan="2" valign="top">4 (5%)
</td>
<td class="Rrule" align="center" valign="top">-
</td>
<td class="Rrule" align="center" colspan="2" valign="top">-
</td>
<td class="Rrule" align="center" valign="top">-
</td>
<td class="Rrule" align="center" valign="top">-
</td>
<td class="Rrule" align="center" valign="top">-
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top">Pharingitis
</td>
<td class="Rrule" align="center" colspan="2" valign="top">-
</td>
<td class="Rrule" align="center" valign="top">-
</td>
<td class="Rrule" align="center" colspan="2" valign="top">-
</td>
<td class="Rrule" align="center" valign="top">-
</td>
<td class="Rrule" align="center" valign="top">6 (8%)
</td>
<td class="Rrule" align="center" valign="top">-
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top"><span class="product-label-link" type="condition" conceptid="77074" conceptname="Joint pain">Arthralgia</span>
</td>
<td class="Rrule" align="center" colspan="2" valign="top">-
</td>
<td class="Rrule" align="center" valign="top">-
</td>
<td class="Rrule" align="center" colspan="2" valign="top">5 (5%)
</td>
<td class="Rrule" align="center" valign="top">4 (5%)
</td>
<td class="Rrule" align="center" valign="top">-
</td>
<td class="Rrule" align="center" valign="top">-
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top"><span class="product-label-link" type="condition" conceptid="26711" conceptname="Chronic pharyngitis">Sore throat</span>
</td>
<td class="Rrule" align="center" colspan="2" valign="top">4 (5%)
</td>
<td class="Rrule" align="center" valign="top">1 (3%)
</td>
<td class="Rrule" align="center" colspan="2" valign="top">5 (5%)
</td>
<td class="Rrule" align="center" valign="top">4 (5%)
</td>
<td class="Rrule" align="center" valign="top">-
</td>
<td class="Rrule" align="center" valign="top">-
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top"><span class="product-label-link" type="condition" conceptid="4316207" conceptname="Injection site pain">Injection site pain</span>
</td>
<td class="Rrule" align="center" colspan="2" valign="top">13 (17%)
</td>
<td class="Rrule" align="center" valign="top">3 (9%)
</td>
<td class="Rrule" align="center" colspan="2" valign="top">14 (13%)
</td>
<td class="Rrule" align="center" valign="top">7 (8%)
</td>
<td class="Rrule" align="center" valign="top">6 (8%)
</td>
<td class="Rrule" align="center" valign="top">2 (3%)
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top"><span class="product-label-link" type="condition" conceptid="4316205" conceptname="Injection site hemorrhage">Injection site ecchymosis</span>
</td>
<td class="Rrule" align="center" colspan="2" valign="top">4 (5%)
</td>
<td class="Rrule" align="center" valign="top">1 (3%)
</td>
<td class="Rrule" align="center" colspan="2" valign="top">4 (4%)
</td>
<td class="Rrule" align="center" valign="top">4 (5%)
</td>
<td class="Rrule" align="center" valign="top">-
</td>
<td class="Rrule" align="center" valign="top">-
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top">Injection site <span class="product-label-link" type="condition" conceptid="137193" conceptname="Erythema">erythema</span>
</td>
<td class="Rrule" align="center" colspan="2" valign="top">5 (7%)
</td>
<td class="Rrule" align="center" valign="top">2 (6%)
</td>
<td class="Rrule" align="center" colspan="2" valign="top">11 (10%)
</td>
<td class="Rrule" align="center" valign="top">5 (6%)
</td>
<td class="Rrule" align="center" valign="top">4 (5%)
</td>
<td class="Rrule" align="center" valign="top">-
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top"><span class="product-label-link" type="condition" conceptid="4317274" conceptname="Injection site mass">Injection site mass</span>
</td>
<td class="Rrule" align="center" colspan="2" valign="top">4 (5%)
</td>
<td class="Rrule" align="center" valign="top">1 (3%)
</td>
<td class="Rrule" align="center" colspan="2" valign="top">-
</td>
<td class="Rrule" align="center" valign="top">-
</td>
<td class="Rrule" align="center" valign="top">-
</td>
<td class="Rrule" align="center" valign="top">-
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top"><span class="product-label-link" type="condition" conceptid="4319319" conceptname="Injection site edema">Injection site edema</span>
</td>
<td class="Rrule" align="center" colspan="2" valign="top">-
</td>
<td class="Rrule" align="center" valign="top">-
</td>
<td class="Rrule" align="center" colspan="2" valign="top">6 (6%)
</td>
<td class="Rrule" align="center" valign="top">2 (2%)
</td>
<td class="Rrule" align="center" valign="top">4 (5%)
</td>
<td class="Rrule" align="center" valign="top">1 (2%)
</td>
</tr>
<tr class="Last">
<td class="Botrule Lrule Rrule" align="left" valign="top"><span class="product-label-link" type="condition" conceptid="4316211" conceptname="Injection site induration">Injection site induration</span>
</td>
<td class="Botrule Rrule" align="center" colspan="2" valign="top">-
</td>
<td class="Botrule Rrule" align="center" valign="top">-
</td>
<td class="Botrule Rrule" align="center" colspan="2" valign="top">14 (13%)
</td>
<td class="Botrule Rrule" align="center" valign="top">3 (3%)
</td>
<td class="Botrule Rrule" align="center" valign="top">7 (9%)
</td>
<td class="Botrule Rrule" align="center" valign="top">-
</td>
</tr>
</tbody>
</table>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="s19"></a><a name="section-6.2.2"></a><p></p>
<p class="First"><span class="Bold">Adults (18 to 64 years of age)</span></p>
<p>In adult subjects, solicited local adverse events occurred with similar frequency in all trials.  The most common solicited adverse events occurring in the first 96 hours after administration (<a href="#t1">Tables 1</a> and <a href="#t2">2</a>) were associated with the injection site (such as <span class="product-label-link" type="condition" conceptid="4329041" conceptname="Pain">pain</span>, <span class="product-label-link" type="condition" conceptid="137193" conceptname="Erythema">erythema</span>, <span class="product-label-link" type="condition" conceptid="4041088" conceptname="Mass">mass</span>, <span class="product-label-link" type="condition" conceptid="4165876" conceptname="Induration">induration</span> and <span class="product-label-link" type="condition" conceptid="4275722" conceptname="Swelling">swelling</span>) but were generally mild/moderate and transient.  The most common solicited systemic adverse events were <span class="product-label-link" type="condition" conceptid="378253" conceptname="Headache">headache</span> and <span class="product-label-link" type="condition" conceptid="442752" conceptname="Muscle pain">myalgia</span>.
</p>
<p>The most common overall events in adult subjects (18-64 years of age) were <span class="product-label-link" type="condition" conceptid="378253" conceptname="Headache">headache</span>, <span class="product-label-link" type="condition" conceptid="4223659" conceptname="Fatigue">fatigue</span>, <span class="product-label-link" type="condition" conceptid="4316202" conceptname="Injection site reaction">injection site reactions</span> (<span class="product-label-link" type="condition" conceptid="4329041" conceptname="Pain">pain</span>, <span class="product-label-link" type="condition" conceptid="4041088" conceptname="Mass">mass</span>, <span class="product-label-link" type="condition" conceptid="137193" conceptname="Erythema">erythema</span>, and <span class="product-label-link" type="condition" conceptid="4165876" conceptname="Induration">induration</span>) and <span class="product-label-link" type="condition" conceptid="4272240" conceptname="Malaise">malaise</span> (<a href="#t3">Table 3</a>).
</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="s20"></a><a name="section-6.2.3"></a><p></p>
<p class="First"><span class="Bold">Geriatric Subjects (65 years of age and older)</span></p>
<p>In geriatric subjects, solicited local and systemic adverse events occurred less frequently than in adult subjects.  The most common solicited local and systemic adverse events were <span class="product-label-link" type="condition" conceptid="4316207" conceptname="Injection site pain">injection site pain</span>, and <span class="product-label-link" type="condition" conceptid="378253" conceptname="Headache">headache</span> (<a href="#t1">Tables 1</a> and <a href="#t2">2</a>).  All were considered mild/moderate and were transient.
</p>
<p>The most common overall events in elderly subjects (≥65 years of age) were <span class="product-label-link" type="condition" conceptid="378253" conceptname="Headache">headache</span> and <span class="product-label-link" type="condition" conceptid="4223659" conceptname="Fatigue">fatigue</span>.
</p>
<p> Only 11 serious adverse events in adult and geriatric subjects (18 years and older) have been reported to date from all the trials performed.  These serious adverse events were a minor <span class="product-label-link" type="condition" conceptid="381316" conceptname="Cerebrovascular accident">stroke</span> experienced by a 67 year old subject 14 days after vaccination (1990), <span class="product-label-link" type="condition" conceptid="4306655" conceptname="Death">death</span> of an 82 year old subject 35 days after vaccination (1990) in very early studies; <span class="product-label-link" type="condition" conceptid="4306655" conceptname="Death">death</span> of a 72 year old subject 19 days after vaccination (1998-1999), a hospitalization for hemorrhoidectomy of a 38 year old male subject (1999-2000), a severe <span class="product-label-link" type="condition" conceptid="4170143" conceptname="Respiratory tract infection">respiratory tract infection</span> experienced by a 74 year old subject 12 days after vaccination (2002-2003), a planned transurethral resection of the prostate in a subject with prior history of <span class="product-label-link" type="condition" conceptid="4016155" conceptname="Prostatism">prostatism</span> (2004-2005), two cases of <span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">influenza</span> (2005-2006), a drug <span class="product-label-link" type="condition" conceptid="4208104" conceptname="Drug overdose">overdose</span> (2005-2006), <span class="product-label-link" type="condition" conceptid="4098112" conceptname="Biliary sludge">cholelithiasis</span> (2005-2006) and a nasal septal operation (2005-2006).  None of these events were considered causally related to vaccination.
</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="s21"></a><a name="section-6.2.4"></a><p></p>
<p class="First"><span class="Bold">Clinical Trial Experience in Pediatric Subjects</span></p>
<p>In 1987 a clinical study was carried out in 38 ‘at risk’ children aged between 4 and 12 years (17 females and 21 males).  To record the safety of FLUVIRIN, participants recorded their symptoms on a diary card during the three days after vaccination and noted any further symptoms they thought were attributable to the vaccine.  The only reactions recorded were <span class="product-label-link" type="condition" conceptid="4082445" conceptname="Tenderness">tenderness</span> at the site of vaccination in 21% of the participants on day 1, which was still present in 16% on day 2 and 5% on day 3.  In one child, the <span class="product-label-link" type="condition" conceptid="4082445" conceptname="Tenderness">tenderness</span> was also accompanied by <span class="product-label-link" type="condition" conceptid="137193" conceptname="Erythema">redness</span> at the site of injection for two days.  The reactions were not age-dependent and there was no bias towards the younger children.
</p>
<p>Three clinical studies were carried out between 1995 and 2004 in a total of 520 pediatric subjects (age range 6 - 47 months).  Of these, 285 healthy subjects plus 41 ‘at risk’ subjects received FLUVIRIN.  No serious adverse events were reported.
</p>
<p>FLUVIRIN and <span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">Influenza</span> A (H1N1) 2009 Monovalent Vaccine should only be used for the immunization of persons aged 4 years and over.
</p>
</div>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="s22"></a><a name="section-6.3"></a><p></p>
<h2>6.3 Postmarketing Experience
</h2>
<p class="First">The following additional adverse reactions have been reported during post-approval use of FLUVIRIN.  Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to vaccine exposure.  Adverse events described here are included because: a) they represent reactions which are known to occur following immunizations generally or <span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">influenza</span> immunizations specifically; b) they are potentially serious; or c) the frequency of reporting.
</p>
<ul class="Disc">
<li>
<span class="Italics">Body as a whole</span>: Local <span class="product-label-link" type="condition" conceptid="4316202" conceptname="Injection site reaction">injection site reactions</span> (including <span class="product-label-link" type="condition" conceptid="4329041" conceptname="Pain">pain</span>, <span class="product-label-link" type="condition" conceptid="4329041" conceptname="Pain">pain</span> limiting limb movement, <span class="product-label-link" type="condition" conceptid="137193" conceptname="Erythema">redness</span>, <span class="product-label-link" type="condition" conceptid="4275722" conceptname="Swelling">swelling</span>, warmth, <span class="product-label-link" type="condition" conceptid="4118793" conceptname="Ecchymosis">ecchymosis</span>, <span class="product-label-link" type="condition" conceptid="4165876" conceptname="Induration">induration</span>), <span class="product-label-link" type="condition" conceptid="4113666" conceptname="Menopausal flushing">hot flashes</span>/flushes; <span class="product-label-link" type="condition" conceptid="4190045" conceptname="Rigor">chills</span>; <span class="product-label-link" type="condition" conceptid="437663" conceptname="Fever">fever</span>; <span class="product-label-link" type="condition" conceptid="4272240" conceptname="Malaise">malaise</span>; <span class="product-label-link" type="condition" conceptid="4190045" conceptname="Rigor">shivering</span>; <span class="product-label-link" type="condition" conceptid="4223659" conceptname="Fatigue">fatigue</span>; <span class="product-label-link" type="condition" conceptid="437113" conceptname="Asthenia">asthenia</span>; facial <span class="product-label-link" type="condition" conceptid="433595" conceptname="Edema">edema</span>.
</li>
<li>
<span class="Italics"><span class="product-label-link" type="condition" conceptid="440371" conceptname="Disorder of immune function">Immune system disorders</span>:</span> <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">Hypersensitivity reactions</span> (including throat and/or mouth <span class="product-label-link" type="condition" conceptid="433595" conceptname="Edema">edema</span>).  In rare cases, <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity reactions</span> have lead to <span class="product-label-link" type="condition" conceptid="441202" conceptname="Anaphylaxis">anaphylactic shock</span> and <span class="product-label-link" type="condition" conceptid="4306655" conceptname="Death">death</span>.
</li>
<li>
<span class="Italics"><span class="product-label-link" type="condition" conceptid="134057" conceptname="Disorder of cardiovascular system">Cardiovascular disorders</span>:</span> <span class="product-label-link" type="condition" conceptid="4137275" conceptname="Vasculitis">Vasculitis</span> (in rare cases with transient renal involvement), <span class="product-label-link" type="condition" conceptid="135360" conceptname="Syncope">syncope</span> shortly after vaccination.
</li>
<li>
<span class="Italics">Digestive disorders:</span> <span class="product-label-link" type="condition" conceptid="80141" conceptname="Functional diarrhea">Diarrhea</span>; <span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">nausea</span>; <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span>; <span class="product-label-link" type="condition" conceptid="200219" conceptname="Abdominal pain">abdominal pain</span>.
</li>
<li>
<span class="Italics">Blood and lymphatic disorders:</span> Local <span class="product-label-link" type="condition" conceptid="315085" conceptname="Lymphadenopathy">lymphadenopathy</span>; transient <span class="product-label-link" type="condition" conceptid="432870" conceptname="Thrombocytopenic disorder">thrombocytopenia</span>.
</li>
<li>
<span class="Italics">Metabolic and nutritional disorders:</span> Loss of appetite.
</li>
<li>
<span class="Italics">Musculoskeletal</span>: <span class="product-label-link" type="condition" conceptid="77074" conceptname="Joint pain">Arthralgia</span>; <span class="product-label-link" type="condition" conceptid="442752" conceptname="Muscle pain">myalgia</span>; <span class="product-label-link" type="condition" conceptid="79908" conceptname="Muscle weakness">myasthenia</span>.
</li>
<li>
<span class="Italics"><span class="product-label-link" type="condition" conceptid="376337" conceptname="Disorder of nervous system">Nervous system disorders</span>:</span> <span class="product-label-link" type="condition" conceptid="378253" conceptname="Headache">Headache</span>; <span class="product-label-link" type="condition" conceptid="4223938" conceptname="Dizziness">dizziness</span>; <span class="product-label-link" type="condition" conceptid="373852" conceptname="Neuralgia">neuralgia</span>; <span class="product-label-link" type="condition" conceptid="4193492" conceptname="Acroparesthesia">paraesthesia</span>; <span class="product-label-link" type="condition" conceptid="381273" conceptname="Confusional state">confusion</span>; <span class="product-label-link" type="condition" conceptid="444413" conceptname="Febrile convulsion">febrile convulsions</span>; Guillain-Barré Syndrome; <span class="product-label-link" type="condition" conceptid="138965" conceptname="Myelitis">myelitis</span> (including <span class="product-label-link" type="condition" conceptid="373189" conceptname="Encephalomyelitis">encephalomyelitis</span> and transverse <span class="product-label-link" type="condition" conceptid="138965" conceptname="Myelitis">myelitis</span>); <span class="product-label-link" type="condition" conceptid="197608" conceptname="Peripheral neuritis in pregnancy">neuropathy</span> (including <span class="product-label-link" type="condition" conceptid="444252" conceptname="Neuritis">neuritis</span>); <span class="product-label-link" type="condition" conceptid="440377" conceptname="Paralysis">paralysis</span> (including Bell’s <span class="product-label-link" type="condition" conceptid="440377" conceptname="Paralysis">Palsy</span>).
</li>
<li>
<span class="Italics"><span class="product-label-link" type="condition" conceptid="320136" conceptname="Disorder of respiratory system">Respiratory disorders</span>:</span> <span class="product-label-link" type="condition" conceptid="312437" conceptname="Dyspnea">Dyspnea</span>; <span class="product-label-link" type="condition" conceptid="77670" conceptname="Chest pain">chest pain</span>; <span class="product-label-link" type="condition" conceptid="254761" conceptname="Cough">cough</span>; <span class="product-label-link" type="condition" conceptid="4226263" conceptname="Pharyngitis">pharyngitis</span>; <span class="product-label-link" type="condition" conceptid="4320791" conceptname="Rhinitis">rhinitis</span>.
</li>
<li>
<span class="Italics">Skin and appendages</span>: <span class="product-label-link" type="condition" conceptid="141651" conceptname="Stevens-Johnson syndrome">Stevens-Johnson syndrome</span>; <span class="product-label-link" type="condition" conceptid="138565" conceptname="Hyperhidrosis">sweating</span>; <span class="product-label-link" type="condition" conceptid="4169287" conceptname="Itching of skin">pruritus</span>; <span class="product-label-link" type="condition" conceptid="139900" conceptname="Urticaria">urticaria</span>; <span class="product-label-link" type="condition" conceptid="140214" conceptname="Eruption">rash</span> (including non-specific, maculopapular, and vesiculobulbous).
</li>
</ul>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="s23"></a><a name="section-6.4"></a><p></p>
<h2>6.4 Other Adverse Reactions Associated with <span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">Influenza</span> Vaccination
</h2>
<p class="First"><span class="product-label-link" type="condition" conceptid="441202" conceptname="Anaphylaxis">Anaphylaxis</span> has been reported after administration of FLUVIRIN.  Although FLUVIRIN and <span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">Influenza</span> A (H1N1) 2009 Monovalent Vaccine contain only a limited quantity of egg protein, this protein can induce <span class="product-label-link" type="condition" conceptid="4223759" conceptname="IgE-mediated allergic disorder">immediate hypersensitivity reactions</span> among persons who have severe <span class="product-label-link" type="condition" conceptid="4188027" conceptname="Food allergy">egg allergy</span>.  <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">Allergic reactions</span> include <span class="product-label-link" type="condition" conceptid="139900" conceptname="Urticaria">hives</span>, <span class="product-label-link" type="condition" conceptid="432791" conceptname="Angioedema">angioedema</span>, <span class="product-label-link" type="condition" conceptid="317009" conceptname="Asthma">allergic asthma</span>, and <span class="product-label-link" type="condition" conceptid="441202" conceptname="Anaphylaxis">systemic anaphylaxis</span> [see CONTRAINDICATIONS (<a href="#s8">4</a>)].
</p>
<p>The 1976 swine <span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">influenza</span> vaccine was associated with an increased frequency of Guillain-Barré syndrome (GBS).  Evidence for a causal relation of GBS with subsequent vaccines prepared from other <span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">influenza</span> viruses is unclear.  If <span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">influenza</span> vaccine does pose a risk, it is probably slightly more than 1 additional case/1 million persons vaccinated.
</p>
<p>Neurological disorders temporally associated with <span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">influenza</span> vaccination such as <span class="product-label-link" type="condition" conceptid="372887" conceptname="Disorder of brain">encephalopathy</span>, <span class="product-label-link" type="condition" conceptid="374954" conceptname="Optic neuritis">optic neuritis</span>/<span class="product-label-link" type="condition" conceptid="197608" conceptname="Peripheral neuritis in pregnancy">neuropathy</span>, partial <span class="product-label-link" type="condition" conceptid="374923" conceptname="Bell's palsy">facial paralysis</span>, and brachial plexus <span class="product-label-link" type="condition" conceptid="197608" conceptname="Peripheral neuritis in pregnancy">neuropathy</span> have been reported.
</p>
<p>Microscopic polyangiitis (<span class="product-label-link" type="condition" conceptid="4137275" conceptname="Vasculitis">vasculitis</span>) has been reported temporally associated with <span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">influenza</span> vaccination.
</p>
</div>
</div>
<div class="Section" data-sectionCode="34073-7">
<a name="s24"></a><a name="section-7"></a><p></p>
<h1>7 DRUG INTERACTIONS
</h1>
<div class="Section" data-sectionCode="42229-5">
<a name="s25"></a><a name="section-7.1"></a><p></p>
<h2>7.1 Concomitant Administration with Other Vaccines
</h2>
<p class="First"> There are no data to assess the concomitant administration of <span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">Influenza</span> A (H1N1) 2009 Monovalent Vaccine with other vaccines.  If <span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">Influenza</span> A (H1N1) 2009 Monovalent Vaccine is to be given at the same time as another injectable vaccine(s), the vaccines should always be administered at different injection sites.
</p>
<p><span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">Influenza</span> A (H1N1) 2009 Monovalent Vaccine should not be mixed with any other vaccine in the same syringe or vial.
</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="s26"></a><a name="section-7.2"></a><p></p>
<h2>7.2 Concurrent Use with Immunosuppressive Therapies
</h2>
<p class="First"> Immunosuppressive therapies, including irradiation, antimetabolites, alkylating agents, cytotoxic drugs, and corticosteroids (used in greater than physiologic doses), may reduce the immune response to <span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">Influenza</span> A (H1N1) 2009 Monovalent Vaccine.
</p>
</div>
</div>
<div class="Section" data-sectionCode="43684-0">
<a name="s27"></a><a name="section-8"></a><p></p>
<h1>8 USE IN SPECIFIC POPULATIONS
</h1>
<p class="First">Novartis’ <span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">Influenza</span> A (H1N1) 2009 Monovalent Vaccine and seasonal trivalent <span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">Influenza</span> Virus Vaccine (FLUVIRIN) are manufactured by the same process.  Available information for FLUVIRIN is provided in this section.
</p>
<div class="Section" data-sectionCode="42228-7">
<a name="s28"></a><a name="section-8.1"></a><p></p>
<h2>8.1 Pregnancy
</h2>
<p class="First">Pregnancy Category C: Animal reproduction studies have not been conducted with <span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">Influenza</span> A (H1N1) 2009 Monovalent Vaccine or FLUVIRIN.  It is also not known whether <span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">Influenza</span> A (H1N1) 2009 Monovalent Vaccine or FLUVIRIN can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity.  <span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">Influenza</span> A (H1N1) 2009 Monovalent Vaccine should be given to a pregnant woman only if clearly needed.
</p>
</div>
<div class="Section" data-sectionCode="34080-2">
<a name="s29"></a><a name="section-8.2"></a><p></p>
<h2>8.3 Nursing Mothers
</h2>
<p class="First">It is not known whether FLUVIRIN or <span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">Influenza</span> A (H1N1) 2009 Monovalent Vaccine is excreted in human milk.  Because many drugs are excreted in human milk, caution should be exercised when <span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">Influenza</span> A (H1N1) 2009 Monovalent Vaccine is administered to a nursing woman.
</p>
</div>
<div class="Section" data-sectionCode="34081-0">
<a name="s30"></a><a name="section-8.3"></a><p></p>
<h2>8.4 Pediatric Use
</h2>
<p class="First">Safety and effectiveness in pediatric subjects below the age of 4 years have not been established. [see ADVERSE REACTIONS (<a href="#s15">6</a>) and CLINICAL STUDIES (<a href="#s37">14</a>)]
</p>
</div>
<div class="Section" data-sectionCode="34082-8">
<a name="s31"></a><a name="section-8.4"></a><p></p>
<h2>8.5 Geriatric Use
</h2>
<p class="First">Since 1997, of the total number of geriatric subjects (n = 397) in clinical studies of FLUVIRIN, 29% of adult subjects were 65 years and over, while 2.1% were 75 years and over.
</p>
<p>Antibody responses were lower in the geriatric population than in younger subjects.  Adverse events occurred less frequently in geriatric subjects (≥65 years) than in younger adults.  Other reported clinical experience has not identified differences in responses between the elderly and younger patients. [See ADVERSE REACTION (<a href="#s15">6</a>) and CLINICAL STUDIES (<a href="#s37">14</a>)].
</p>
</div>
</div>
<div class="Section" data-sectionCode="34089-3">
<a name="s32"></a><a name="section-9"></a><p></p>
<h1>11 DESCRIPTION
</h1>
<p class="First"><span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">Influenza</span> A (H1N1) 2009 Monovalent Vaccine is a sub-unit (purified surface antigen) <span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">influenza</span> virus vaccine prepared from virus propagated in the allantoic cavity of embryonated hens’ eggs inoculated with a specific type of <span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">influenza</span> virus suspension containing neomycin and polymyxin.  The <span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">influenza</span> virus <span class="product-label-link" type="condition" conceptid="4168796" conceptname="Muscle strain">strain</span> is harvested and clarified by centrifugation and filtration prior to inactivation with betapropiolactone.  The inactivated virus is concentrated and purified by zonal centrifugation.  The surface antigens, hemagglutinin and neuraminidase, are obtained from the <span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">influenza</span> virus particle by further centrifugation in the presence of nonylphenol ethoxylate, a process which removes most of the internal proteins.  The nonylphenol ethoxylate is removed from the surface antigen preparation.
</p>
<p><span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">Influenza</span> A (H1N1) 2009 Monovalent Vaccine is a homogenized, sterile, slightly opalescent suspension in a phosphate buffered saline.  <span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">Influenza</span> A (H1N1) 2009 Monovalent Vaccine is formulated to contain 15 mcg hemagglutinin (HA) per 0.5-mL dose of the following virus <span class="product-label-link" type="condition" conceptid="4168796" conceptname="Muscle strain">strain</span>: A/California/7/2009 (H1N1)v-like virus. 
</p>
<p>The 0.5-mL prefilled syringe presentation is formulated without preservative. Thimerosal, a mercury derivative used during manufacturing, is removed by subsequent purification steps to a trace amount (≤ 1 mcg mercury per 0.5-mL dose).
</p>
<p>The 5-mL multidose vial formulation contains thimerosal, a mercury derivative, added as a preservative.  Each 0.5-mL dose from the multidose vial contains 25 mcg mercury.
</p>
<p>Each dose from the multidose vial or from the prefilled syringe may also contain residual amounts of egg proteins (≤ 1 mcg ovalbumin), polymyxin (≤ 3.75 mcg), neomycin (≤ 2.5 mcg), betapropiolactone (not more than 0.5 mcg) and nonylphenol ethoxylate (not more than 0.015% w/v).
</p>
<p>The multidose vial stopper and the syringe stopper/plunger do not contain latex.
</p>
</div>
<div class="Section" data-sectionCode="34090-1">
<a name="s33"></a><a name="section-10"></a><p></p>
<h1>12 CLINICAL PHARMACOLOGY
</h1>
<div class="Section" data-sectionCode="43679-0">
<a name="s34"></a><a name="section-10.1"></a><p></p>
<h2>12.1 Mechanism of Action
</h2>
<p class="First"><span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">Influenza</span> illness and its complications follow <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infection</span> with <span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">influenza</span> viruses.  Global surveillance of <span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">influenza</span> identifies yearly antigenic variants.  For example, since 1977, antigenic variants of <span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">influenza</span> A (H1N1 and H3N2) viruses and <span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">influenza</span> B viruses have been in global circulation.  Specific levels of hemagglutination inhibition (HI) antibody titers post-vaccination with inactivated <span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">influenza</span> virus vaccine have not been correlated with protection from <span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">influenza</span> illness.  In some human studies, antibody titer of ≥1:40 have been associated with protection from <span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">influenza</span> illness in up to 50% of subjects [see REFERENCES (<a href="#p2">15.2</a>, <a href="#p3">15.3</a>)].
</p>
<p>Antibody against one <span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">influenza</span> virus type or subtype confers limited or no protection against another.  Furthermore, antibody to one antigenic variant of <span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">influenza</span> virus might not protect against a new antigenic variant of the same type or subtype.
</p>
</div>
</div>
<div class="Section" data-sectionCode="43680-8">
<a name="s35"></a><a name="section-11"></a><p></p>
<h1>13 NONCLINICAL TOXICOLOGY
</h1>
<div class="Section" data-sectionCode="34083-6">
<a name="s36"></a><a name="section-11.1"></a><p></p>
<h2>13.1 Carcinogenesis, Mutagenesis, Impairment of Fertility
</h2>
<p class="First"> Neither FLUVIRIN nor the <span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">Influenza</span> A (H1N1) 2009 Monovalent Vaccine have been evaluated for carcinogenic or mutagenic potential, or for impairment of fertility.
</p>
</div>
</div>
<div class="Section" data-sectionCode="34092-7">
<a name="s37"></a><a name="section-12"></a><p></p>
<h1>14 CLINICAL STUDIES
</h1>
<p class="First">Novartis’ <span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">Influenza</span> A (H1N1) 2009 Monovalent Vaccine and seasonal trivalent <span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">Influenza</span> Virus Vaccine (FLUVIRIN) are manufactured by the same process.  Data in this section were obtained in clinical studies conducted with FLUVIRIN.  
</p>
<p>Between 1982 and 1991, twelve clinical studies were conducted in healthy adult and geriatric subjects and one in children between 4 and 12 years of age who were considered to be ‘at risk’.  Since 1991 an annual clinical study has been conducted in the UK in healthy adults aged 18 years or older.  FLUVIRIN was also used as a control in a US clinical trial in adults (18-49 years of age).  In all the trials, blood samples were taken prior to vaccination and approximately three weeks after vaccination to assess the immunogenic response to vaccination by measurement of anti-HA antibodies.
</p>
<p>Three clinical studies were carried out between 1995 and 2004 in a total of 520 pediatric subjects (age range 6-48 months).  Of these, 285 healthy subjects plus 41 ‘at risk’ pediatric subjects, received FLUVIRIN.
</p>
<p><span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">Influenza</span> A (H1N1) 2009 Monovalent Vaccine should only be used for the immunization of persons aged 4 years and over.
</p>
<div class="Section" data-sectionCode="42229-5">
<a name="s38"></a><a name="section-12.1"></a><p></p>
<h2>14.1 Immunogenicity in Adults (18 to 64 years of age)
</h2>
<p class="First"><a href="#t4">Tables 4</a> and <a href="#t5">5</a> show the immunogenicity data for the adult age group.  The seven clinical studies presented enrolled a total of 774 adult subjects.  In the adult group, for all antigens (A/H1N1, A/H3N2 and B) at least one of the following point estimate criteria was met: the proportion of subjects with seroconversion (post-vaccination titer ≥1:40 from a pre-vaccination titer &lt;1:10) or significant increase (at least a four-fold increase from pre-vaccination titer ≥1:10) in antibody titer was greater than 40%; the geometric mean titer (GMT) increase was &gt;2.5; the proportion of subjects with a post-vaccination hemagglutination inhibition (HI) antibody titer ≥1:40 was greater than 70%.
</p>
<a name="t4"></a><table width="100%">
<caption><span>TABLE 4 Summary of the Seroconversion and Proportion of Subjects Achieving an HI titer ≥1:40 for Adult Subjects
</span></caption>
<col align="left" width="39.283%">
<col align="left" width="11.761%">
<col align="left" width="7.287%">
<col align="left" width="6.637%">
<col align="left" width="10.611%">
<col align="left" width="6.974%">
<col align="left" width="6.637%">
<col align="left" width="10.811%">
<thead>
<tr class="First">
<th class="Botrule Lrule Rrule Toprule" align="center" rowspan="2" valign="middle">Year/<span class="product-label-link" type="condition" conceptid="4168796" conceptname="Muscle strain">Strain</span>
</th>
<th class="Botrule Rrule Toprule" align="center" rowspan="2" valign="middle">No. of subjects
</th>
<th class="Botrule Rrule Toprule" align="center" colspan="3" valign="middle">Seroconversion <span class="Sup">∞</span>
</th>
<th class="Botrule Rrule Toprule" align="center" colspan="3" valign="middle">HI titer ≥1:40<span class="Sup">¥</span>
</th>
</tr>
<tr class="Last">
<th class="Botrule Rrule" align="center" valign="middle">N
</th>
<th class="Botrule Rrule" align="center" valign="middle">%
</th>
<th class="Botrule Rrule" align="center" valign="middle">95% CI<span class="Sup">Φ</span>
</th>
<th class="Botrule Rrule" align="center" valign="middle">N
</th>
<th class="Botrule Rrule" align="center" valign="middle">%
</th>
<th class="Botrule Rrule" align="center" valign="middle">95% CI<span class="Sup">Φ</span>
</th>
</tr>
</thead>
<tfoot>
<tr class="First"><td align="left" colspan="8" valign="top"><p class="First Footnote">∞ Seroconversion: proportion of subjects with either a post-vaccination HI titer ≥1:40 from a pre-vaccination titer &lt;1:10 or at least a four-fold increase from pre-vaccination HI titer ≥1:10 in antibody titer.
</p></td></tr>
<tr><td align="left" colspan="8" valign="top"><p class="First Footnote">¥ HI titer ≥1:40: proportion of subjects with a post-vaccination titer ≥ 1:40.
</p></td></tr>
<tr class="Last"><td align="left" colspan="8" valign="top"><p class="First Footnote">Φ 95% CI: 95% confidence interval
</p></td></tr>
</tfoot>
<tbody>
<tr class="First">
<td class="Lrule Rrule" align="left" valign="top"><span class="Bold">1998-1999</span></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top">    A/H1N1
</td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle">48
</td>
<td class="Rrule" align="center" valign="middle">73
</td>
<td class="Rrule" align="center" valign="middle">(62, 83)
</td>
<td class="Rrule" align="center" valign="middle">50
</td>
<td class="Rrule" align="center" valign="middle">76
</td>
<td class="Rrule" align="center" valign="middle">(65, 86)
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top">    A/H3N2
</td>
<td class="Rrule" align="center" valign="middle">66
</td>
<td class="Rrule" align="center" valign="middle">43
</td>
<td class="Rrule" align="center" valign="middle">65
</td>
<td class="Rrule" align="center" valign="middle">(54, 77)
</td>
<td class="Rrule" align="center" valign="middle">47
</td>
<td class="Rrule" align="center" valign="middle">71
</td>
<td class="Rrule" align="center" valign="middle">(60, 82)
</td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" align="left" valign="top">    B
</td>
<td class="Botrule Rrule" align="center" valign="middle"></td>
<td class="Botrule Rrule" align="center" valign="middle">42
</td>
<td class="Botrule Rrule" align="center" valign="middle">64
</td>
<td class="Botrule Rrule" align="center" valign="middle">(52, 75)
</td>
<td class="Botrule Rrule" align="center" valign="middle">62
</td>
<td class="Botrule Rrule" align="center" valign="middle">94
</td>
<td class="Botrule Rrule" align="center" valign="middle">(88, 100)
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top"><span class="Bold">1999-2000</span></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top">    A/H1N1
</td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle">45
</td>
<td class="Rrule" align="center" valign="middle">59
</td>
<td class="Rrule" align="center" valign="middle">(48, 70)
</td>
<td class="Rrule" align="center" valign="middle">50
</td>
<td class="Rrule" align="center" valign="middle">66
</td>
<td class="Rrule" align="center" valign="middle">(55, 76)
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top">    A/H3N2
</td>
<td class="Rrule" align="center" valign="middle">76
</td>
<td class="Rrule" align="center" valign="middle">51
</td>
<td class="Rrule" align="center" valign="middle">67
</td>
<td class="Rrule" align="center" valign="middle">(57, 78)
</td>
<td class="Rrule" align="center" valign="middle">66
</td>
<td class="Rrule" align="center" valign="middle">87
</td>
<td class="Rrule" align="center" valign="middle">(79, 94)
</td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" align="left" valign="top">    B
</td>
<td class="Botrule Rrule" align="center" valign="middle"></td>
<td class="Botrule Rrule" align="center" valign="middle">53
</td>
<td class="Botrule Rrule" align="center" valign="middle">70
</td>
<td class="Botrule Rrule" align="center" valign="middle">(59, 80)
</td>
<td class="Botrule Rrule" align="center" valign="middle">75
</td>
<td class="Botrule Rrule" align="center" valign="middle">99
</td>
<td class="Botrule Rrule" align="center" valign="middle">(96, 100)
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top"><span class="Bold">2000-2001</span></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top">    A/H1N1
</td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle">41
</td>
<td class="Rrule" align="center" valign="middle">55
</td>
<td class="Rrule" align="center" valign="middle">(44, 67)
</td>
<td class="Rrule" align="center" valign="middle">41
</td>
<td class="Rrule" align="center" valign="middle">55
</td>
<td class="Rrule" align="center" valign="middle">(44, 67)
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top">    A/H3N2
</td>
<td class="Rrule" align="center" valign="middle">74
</td>
<td class="Rrule" align="center" valign="middle">45
</td>
<td class="Rrule" align="center" valign="middle">61
</td>
<td class="Rrule" align="center" valign="middle">(50, 72)
</td>
<td class="Rrule" align="center" valign="middle">52
</td>
<td class="Rrule" align="center" valign="middle">84
</td>
<td class="Rrule" align="center" valign="middle">(75, 92)
</td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" align="left" valign="top">    B
</td>
<td class="Botrule Rrule" align="center" valign="middle"></td>
<td class="Botrule Rrule" align="center" valign="middle">50
</td>
<td class="Botrule Rrule" align="center" valign="middle">68
</td>
<td class="Botrule Rrule" align="center" valign="middle">(57, 78)
</td>
<td class="Botrule Rrule" align="center" valign="middle">73
</td>
<td class="Botrule Rrule" align="center" valign="middle">99
</td>
<td class="Botrule Rrule" align="center" valign="middle">(96, 100)
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top"><span class="Bold">2001-2002</span></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top">    A/H1N1
</td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle">44
</td>
<td class="Rrule" align="center" valign="middle">59
</td>
<td class="Rrule" align="center" valign="middle">(48, 70)
</td>
<td class="Rrule" align="center" valign="middle">48
</td>
<td class="Rrule" align="center" valign="middle">64
</td>
<td class="Rrule" align="center" valign="middle">(53, 75)
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top">    A/H3N2
</td>
<td class="Rrule" align="center" valign="middle">75
</td>
<td class="Rrule" align="center" valign="middle">46
</td>
<td class="Rrule" align="center" valign="middle">61
</td>
<td class="Rrule" align="center" valign="middle">(50, 72)
</td>
<td class="Rrule" align="center" valign="middle">68
</td>
<td class="Rrule" align="center" valign="middle">91
</td>
<td class="Rrule" align="center" valign="middle">(84, 97)
</td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" align="left" valign="top">    B
</td>
<td class="Botrule Rrule" align="center" valign="middle"></td>
<td class="Botrule Rrule" align="center" valign="middle">42
</td>
<td class="Botrule Rrule" align="center" valign="middle">56
</td>
<td class="Botrule Rrule" align="center" valign="middle">(45, 67)
</td>
<td class="Botrule Rrule" align="center" valign="middle">66
</td>
<td class="Botrule Rrule" align="center" valign="middle">88
</td>
<td class="Botrule Rrule" align="center" valign="middle">(81, 95)
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top"><span class="Bold">2002-2003</span></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top">    A/H1N1
</td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle">62
</td>
<td class="Rrule" align="center" valign="middle">58
</td>
<td class="Rrule" align="center" valign="middle">(49, 68)
</td>
<td class="Rrule" align="center" valign="middle">73
</td>
<td class="Rrule" align="center" valign="middle">69
</td>
<td class="Rrule" align="center" valign="middle">(60, 78)
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top">    A/H3N2
</td>
<td class="Rrule" align="center" valign="middle">106
</td>
<td class="Rrule" align="center" valign="middle">72
</td>
<td class="Rrule" align="center" valign="middle">68
</td>
<td class="Rrule" align="center" valign="middle">(59, 77)
</td>
<td class="Rrule" align="center" valign="middle">93
</td>
<td class="Rrule" align="center" valign="middle">88
</td>
<td class="Rrule" align="center" valign="middle">(81, 94)
</td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" align="left" valign="top">    B
</td>
<td class="Botrule Rrule" align="center" valign="middle"></td>
<td class="Botrule Rrule" align="center" valign="middle">78
</td>
<td class="Botrule Rrule" align="center" valign="middle">74
</td>
<td class="Botrule Rrule" align="center" valign="middle">(65, 82)
</td>
<td class="Botrule Rrule" align="center" valign="middle">101
</td>
<td class="Botrule Rrule" align="center" valign="middle">95
</td>
<td class="Botrule Rrule" align="center" valign="middle">(91, 99)
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top"><span class="Bold">2004-2005</span></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top">    A/H1N1
</td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle">52
</td>
<td class="Rrule" align="center" valign="middle">70
</td>
<td class="Rrule" align="center" valign="middle">(59, 80)
</td>
<td class="Rrule" align="center" valign="middle">66
</td>
<td class="Rrule" align="center" valign="middle">89
</td>
<td class="Rrule" align="center" valign="middle">(80, 95)
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top">    A/H3N2
</td>
<td class="Rrule" align="center" valign="middle">74
</td>
<td class="Rrule" align="center" valign="middle">60
</td>
<td class="Rrule" align="center" valign="middle">81
</td>
<td class="Rrule" align="center" valign="middle">(70, 89)
</td>
<td class="Rrule" align="center" valign="middle">73
</td>
<td class="Rrule" align="center" valign="middle">99
</td>
<td class="Rrule" align="center" valign="middle">(93, 100)
</td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" align="left" valign="top">    B
</td>
<td class="Botrule Rrule" align="center" valign="middle"></td>
<td class="Botrule Rrule" align="center" valign="middle">57
</td>
<td class="Botrule Rrule" align="center" valign="middle">77
</td>
<td class="Botrule Rrule" align="center" valign="middle">(66, 86)
</td>
<td class="Botrule Rrule" align="center" valign="middle">69
</td>
<td class="Botrule Rrule" align="center" valign="middle">93
</td>
<td class="Botrule Rrule" align="center" valign="middle">(85, 98)
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top"><span class="Bold">2005-2006</span></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top">    A/H1N1
</td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle">191
</td>
<td class="Rrule" align="center" valign="middle">63
</td>
<td class="Rrule" align="center" valign="middle">(57, 68)
</td>
<td class="Rrule" align="center" valign="middle">296
</td>
<td class="Rrule" align="center" valign="middle">98
</td>
<td class="Rrule" align="center" valign="middle">(95, 99)
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top">    A/H3N2
</td>
<td class="Rrule" align="center" valign="middle">303
</td>
<td class="Rrule" align="center" valign="middle">273
</td>
<td class="Rrule" align="center" valign="middle">90
</td>
<td class="Rrule" align="center" valign="middle">(86, 93)
</td>
<td class="Rrule" align="center" valign="middle">294
</td>
<td class="Rrule" align="center" valign="middle">97
</td>
<td class="Rrule" align="center" valign="middle">(94, 99)
</td>
</tr>
<tr class="Last">
<td class="Botrule Lrule Rrule" align="left" valign="top">    B
</td>
<td class="Botrule Rrule" align="center" valign="middle"></td>
<td class="Botrule Rrule" align="center" valign="middle">213
</td>
<td class="Botrule Rrule" align="center" valign="middle">70
</td>
<td class="Botrule Rrule" align="center" valign="middle">(65, 75)
</td>
<td class="Botrule Rrule" align="center" valign="middle">263
</td>
<td class="Botrule Rrule" align="center" valign="middle">87
</td>
<td class="Botrule Rrule" align="center" valign="middle">(82, 90)
</td>
</tr>
</tbody>
</table>
<a name="t5"></a><table width="100%">
<caption><span>TABLE 5 Summary of the Geometric Mean Hemagglutination Inhibition Antibody Titers, Pre- and Post-Immunization, for Adult Subjects
</span></caption>
<col align="left" width="30.140%">
<col align="left" width="11.169%">
<col align="left" width="13.652%">
<col align="left" width="13.652%">
<col align="left" width="11.385%">
<col align="left" width="20.002%">
<thead>
<tr class="First">
<th class="Botrule Lrule Rrule Toprule" align="center" rowspan="2" valign="middle">Year/<span class="product-label-link" type="condition" conceptid="4168796" conceptname="Muscle strain">Strain</span>
</th>
<th class="Botrule Rrule Toprule" align="center" rowspan="2" valign="middle">No. of subjects
</th>
<th class="Botrule Rrule Toprule" align="center" colspan="4" valign="middle">Geometric Mean Titer (GMT)
</th>
</tr>
<tr class="Last">
<th class="Botrule Rrule" align="center" valign="middle">Pre-vaccination
</th>
<th class="Botrule Rrule" align="center" valign="middle">Post-vaccination
</th>
<th class="Botrule Rrule" align="center" valign="middle">Fold Increase
</th>
<th class="Botrule Rrule" align="center" valign="middle">(95% CI)*
</th>
</tr>
</thead>
<tfoot><tr class="First Last"><td align="left" colspan="6" valign="top"><p class="First Footnote">* 95% CI: 95% confidence interval
</p></td></tr></tfoot>
<tbody>
<tr class="First">
<td class="Lrule Rrule" align="left" valign="top"><span class="Bold">1998-1999</span></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top">    A/H1N1
</td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle">7.26
</td>
<td class="Rrule" align="center" valign="middle">160.87
</td>
<td class="Rrule" align="center" valign="middle">22.16
</td>
<td class="Rrule" align="center" valign="middle">(14.25, 34.46)
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top">    A/H3N2
</td>
<td class="Rrule" align="center" valign="middle">66
</td>
<td class="Rrule" align="center" valign="middle">8.23
</td>
<td class="Rrule" align="center" valign="middle">87.02
</td>
<td class="Rrule" align="center" valign="middle">10.57
</td>
<td class="Rrule" align="center" valign="middle">(6.91, 16.16)
</td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" align="left" valign="top">    B
</td>
<td class="Botrule Rrule" align="center" valign="middle"></td>
<td class="Botrule Rrule" align="center" valign="middle">20.97
</td>
<td class="Botrule Rrule" align="center" valign="middle">231.07
</td>
<td class="Botrule Rrule" align="center" valign="middle">110.2
</td>
<td class="Botrule Rrule" align="center" valign="middle">(6.90, 17.59)
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top"><span class="Bold">1999-2000</span></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top">    A/H1N1
</td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle">7.43
</td>
<td class="Rrule" align="center" valign="middle">58.95
</td>
<td class="Rrule" align="center" valign="middle">7.93
</td>
<td class="Rrule" align="center" valign="middle">(5.73, 10.97)
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top">    A/H3N2
</td>
<td class="Rrule" align="center" valign="middle">76
</td>
<td class="Rrule" align="center" valign="middle">15.29
</td>
<td class="Rrule" align="center" valign="middle">122.83
</td>
<td class="Rrule" align="center" valign="middle">8.03
</td>
<td class="Rrule" align="center" valign="middle">(5.80, 11.13)
</td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" align="left" valign="top">    B
</td>
<td class="Botrule Rrule" align="center" valign="middle"></td>
<td class="Botrule Rrule" align="center" valign="middle">25.70
</td>
<td class="Botrule Rrule" align="center" valign="middle">254.76
</td>
<td class="Botrule Rrule" align="center" valign="middle">9.91
</td>
<td class="Botrule Rrule" align="center" valign="middle">(6.97, 14.10)
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top"><span class="Bold">2000-2001</span></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top">    A/H1N1
</td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle">5.42
</td>
<td class="Rrule" align="center" valign="middle">33.80
</td>
<td class="Rrule" align="center" valign="middle">6.24
</td>
<td class="Rrule" align="center" valign="middle">(4.49, 8.69)
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top">    A/H3N2
</td>
<td class="Rrule" align="center" valign="middle">74
</td>
<td class="Rrule" align="center" valign="middle">15.98
</td>
<td class="Rrule" align="center" valign="middle">126.01
</td>
<td class="Rrule" align="center" valign="middle">7.89
</td>
<td class="Rrule" align="center" valign="middle">(5.61, 11.09)
</td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" align="left" valign="top">    B
</td>
<td class="Botrule Rrule" align="center" valign="middle"></td>
<td class="Botrule Rrule" align="center" valign="middle">26.24
</td>
<td class="Botrule Rrule" align="center" valign="middle">308.25
</td>
<td class="Botrule Rrule" align="center" valign="middle">11.75
</td>
<td class="Botrule Rrule" align="center" valign="middle">(7.73, 17.85)
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top"><span class="Bold">2001-2002</span></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top">    A/H1N1
</td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle">7.76
</td>
<td class="Rrule" align="center" valign="middle">54.78
</td>
<td class="Rrule" align="center" valign="middle">7.06
</td>
<td class="Rrule" align="center" valign="middle">(5.24, 9.52)
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top">    A/H3N2
</td>
<td class="Rrule" align="center" valign="middle">75
</td>
<td class="Rrule" align="center" valign="middle">23.67
</td>
<td class="Rrule" align="center" valign="middle">153.81
</td>
<td class="Rrule" align="center" valign="middle">6.50
</td>
<td class="Rrule" align="center" valign="middle">(4.78, 8.84)
</td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" align="left" valign="top">    B
</td>
<td class="Botrule Rrule" align="center" valign="middle"></td>
<td class="Botrule Rrule" align="center" valign="middle">19.91
</td>
<td class="Botrule Rrule" align="center" valign="middle">107.53
</td>
<td class="Botrule Rrule" align="center" valign="middle">5.40
</td>
<td class="Botrule Rrule" align="center" valign="middle">(3.95, 7.38)
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top"><span class="Bold">2002-2003</span></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top">    A/H1N1
</td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle">7.78
</td>
<td class="Rrule" align="center" valign="middle">60.39
</td>
<td class="Rrule" align="center" valign="middle">7.77
</td>
<td class="Rrule" align="center" valign="middle">(5.81, 10.39)
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top">    A/H3N2
</td>
<td class="Rrule" align="center" valign="middle">106
</td>
<td class="Rrule" align="center" valign="middle">23.32
</td>
<td class="Rrule" align="center" valign="middle">292.03
</td>
<td class="Rrule" align="center" valign="middle">12.52
</td>
<td class="Rrule" align="center" valign="middle">(8.77, 17.87)
</td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" align="left" valign="top">    B
</td>
<td class="Botrule Rrule" align="center" valign="middle"></td>
<td class="Botrule Rrule" align="center" valign="middle">30.20
</td>
<td class="Botrule Rrule" align="center" valign="middle">314.11
</td>
<td class="Botrule Rrule" align="center" valign="middle">10.40
</td>
<td class="Botrule Rrule" align="center" valign="middle">(7.54, 14.34)
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top"><span class="Bold">2004-2005</span></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top">    A/H1N1
</td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle">13
</td>
<td class="Rrule" align="center" valign="middle">159
</td>
<td class="Rrule" align="center" valign="middle">12
</td>
<td class="Rrule" align="center" valign="middle">(8.39, 17)
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top">    A/H3N2
</td>
<td class="Rrule" align="center" valign="middle">74
</td>
<td class="Rrule" align="center" valign="middle">37
</td>
<td class="Rrule" align="center" valign="middle">658
</td>
<td class="Rrule" align="center" valign="middle">18
</td>
<td class="Rrule" align="center" valign="middle">(12, 26)
</td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" align="left" valign="top">    B
</td>
<td class="Botrule Rrule" align="center" valign="middle"></td>
<td class="Botrule Rrule" align="center" valign="middle">15
</td>
<td class="Botrule Rrule" align="center" valign="middle">156
</td>
<td class="Botrule Rrule" align="center" valign="middle">11
</td>
<td class="Botrule Rrule" align="center" valign="middle">(7.87, 14)
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top"><span class="Bold">2005-2006</span></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top">    A/H1N1
</td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle">29
</td>
<td class="Rrule" align="center" valign="middle">232
</td>
<td class="Rrule" align="center" valign="middle">8
</td>
<td class="Rrule" align="center" valign="middle">(6.68, 9.59)
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top">    A/H3N2
</td>
<td class="Rrule" align="center" valign="middle">303
</td>
<td class="Rrule" align="center" valign="middle">14
</td>
<td class="Rrule" align="center" valign="middle">221
</td>
<td class="Rrule" align="center" valign="middle">15
</td>
<td class="Rrule" align="center" valign="middle">(14, 17)
</td>
</tr>
<tr class="Last">
<td class="Botrule Lrule Rrule" align="left" valign="top">    B
</td>
<td class="Botrule Rrule" align="center" valign="middle"></td>
<td class="Botrule Rrule" align="center" valign="middle">13
</td>
<td class="Botrule Rrule" align="center" valign="middle">83
</td>
<td class="Botrule Rrule" align="center" valign="middle">6.5
</td>
<td class="Botrule Rrule" align="center" valign="middle">(5.73, 7.37)
</td>
</tr>
</tbody>
</table>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="s39"></a><a name="section-12.2"></a><p></p>
<h2>14.2 Immunogenicity in Geriatric Subjects (65 years of age and older)
</h2>
<p class="First"><a href="#t6">Tables 6</a> and <a href="#t7">7</a> show the immunogenicity of FLUVIRIN in the geriatric age group.  The six clinical studies presented enrolled a total of 296 geriatric subjects.  For each of the <span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">influenza</span> antigens, the percentage of subjects who achieved seroconversion and the percentage of subjects who achieved HI titers of ≥1:40 are shown, as well as the fold increase in GMT.
</p>
<p>For all antigens (A/H1N1, A/H3N2 and B) at least one of the following point estimate criteria was met: the proportion of subjects with seroconversion (post-vaccination titer ≥1:40 from a pre-vaccination titer &lt;1:10) or significant increase (at least a four-fold increase from pre-vaccination titer ≥1:10) in antibody titer was greater than 30%; the geometric mean titer (GMT) increase was &gt;2.0; the proportion of subjects with a post-vaccination hemagglutination inhibition (HI) antibody titer ≥1:40 was greater than 60%. The pre-specified efficacy criteria were met in each study, although a relatively lower immunogenicity of A/H1N1 <span class="product-label-link" type="condition" conceptid="4168796" conceptname="Muscle strain">strain</span> was seen in the last four studies (the same <span class="product-label-link" type="condition" conceptid="4168796" conceptname="Muscle strain">strain</span> was in each of the formulations).
</p>
<a name="t6"></a><table width="100%">
<caption><span>TABLE 6 Summary of the Seroconversion and Proportion of Subjects Achieving an HI titer ≥1:40 for Geriatric Subjects
</span></caption>
<col align="left" width="39.300%">
<col align="left" width="11.775%">
<col align="left" width="6.725%">
<col align="left" width="6.700%">
<col align="left" width="10.775%">
<col align="left" width="6.338%">
<col align="left" width="7.263%">
<col align="left" width="11.125%">
<thead>
<tr class="First">
<th class="Botrule Lrule Rrule Toprule" align="center" rowspan="2" valign="middle">Year/<span class="product-label-link" type="condition" conceptid="4168796" conceptname="Muscle strain">Strain</span>
</th>
<th class="Botrule Rrule Toprule" align="center" rowspan="2" valign="middle">No. of subjects
</th>
<th class="Botrule Rrule Toprule" align="center" colspan="3" valign="middle">Seroconversion <span class="Sup">∞</span>
</th>
<th class="Botrule Rrule Toprule" align="center" colspan="3" valign="middle">HI titer ≥1:40<span class="Sup">¥</span>
</th>
</tr>
<tr class="Last">
<th class="Botrule Rrule" align="center" valign="middle">N
</th>
<th class="Botrule Rrule" align="center" valign="middle">%
</th>
<th class="Botrule Rrule" align="center" valign="middle">95% CI<span class="Sup">Φ</span>
</th>
<th class="Botrule Rrule" align="center" valign="middle">N
</th>
<th class="Botrule Rrule" align="center" valign="middle">%
</th>
<th class="Botrule Rrule" align="center" valign="middle">95% CI<span class="Sup">Φ</span>
</th>
</tr>
</thead>
<tfoot>
<tr class="First"><td align="left" colspan="8" valign="top"><p class="First Footnote">∞ Seroconversion: proportion of subjects with either a post-vaccination HI titer ≥1:40 from a pre-vaccination titer &lt;1:10 or at least a four-fold increase from pre-vaccination HI titer ≥1:10 in antibody titer
</p></td></tr>
<tr><td align="left" colspan="8" valign="top"><p class="First Footnote">¥ HI titer ≥1:40: proportion of subjects with a post-vaccination titer ≥1:40
</p></td></tr>
<tr class="Last"><td align="left" colspan="8" valign="top"><p class="First Footnote">Φ 95% CI: 95% confidence interval
</p></td></tr>
</tfoot>
<tbody>
<tr class="First">
<td class="Lrule Rrule" align="left" valign="top"><span class="Bold">1998-1999</span></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top">    A/H1N1
</td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle">33
</td>
<td class="Rrule" align="center" valign="middle">79
</td>
<td class="Rrule" align="center" valign="middle">(66, 91)
</td>
<td class="Rrule" align="center" valign="middle">38
</td>
<td class="Rrule" align="center" valign="middle">90
</td>
<td class="Rrule" align="center" valign="middle">(82, 99)
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top">    A/H3N2
</td>
<td class="Rrule" align="center" valign="middle">42
</td>
<td class="Rrule" align="center" valign="middle">33
</td>
<td class="Rrule" align="center" valign="middle">79
</td>
<td class="Rrule" align="center" valign="middle">(66, 91)
</td>
<td class="Rrule" align="center" valign="middle">36
</td>
<td class="Rrule" align="center" valign="middle">86
</td>
<td class="Rrule" align="center" valign="middle">(75, 96)
</td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" align="left" valign="top">    B
</td>
<td class="Botrule Rrule" align="center" valign="middle"></td>
<td class="Botrule Rrule" align="center" valign="middle">13
</td>
<td class="Botrule Rrule" align="center" valign="middle">31
</td>
<td class="Botrule Rrule" align="center" valign="middle">(17, 45)
</td>
<td class="Botrule Rrule" align="center" valign="middle">42
</td>
<td class="Botrule Rrule" align="center" valign="middle">100
</td>
<td class="Botrule Rrule" align="center" valign="middle">(100, 100)
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top"><span class="Bold">1999-2000</span></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top">    A/H1N1
</td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle">10
</td>
<td class="Rrule" align="center" valign="middle">29
</td>
<td class="Rrule" align="center" valign="middle">(14, 45)
</td>
<td class="Rrule" align="center" valign="middle">23
</td>
<td class="Rrule" align="center" valign="middle">68
</td>
<td class="Rrule" align="center" valign="middle">(52, 83)
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top">    A/H3N2
</td>
<td class="Rrule" align="center" valign="middle">34
</td>
<td class="Rrule" align="center" valign="middle">18
</td>
<td class="Rrule" align="center" valign="middle">53
</td>
<td class="Rrule" align="center" valign="middle">(36, 70)
</td>
<td class="Rrule" align="center" valign="middle">31
</td>
<td class="Rrule" align="center" valign="middle">91
</td>
<td class="Rrule" align="center" valign="middle">(82, 100)
</td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" align="left" valign="top">    B
</td>
<td class="Botrule Rrule" align="center" valign="middle"></td>
<td class="Botrule Rrule" align="center" valign="middle">9
</td>
<td class="Botrule Rrule" align="center" valign="middle">26
</td>
<td class="Botrule Rrule" align="center" valign="middle">(12, 41)
</td>
<td class="Botrule Rrule" align="center" valign="middle">32
</td>
<td class="Botrule Rrule" align="center" valign="middle">94
</td>
<td class="Botrule Rrule" align="center" valign="middle">(86, 100)
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top"><span class="Bold">2000-2001</span></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top">    A/H1N1
</td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle">5
</td>
<td class="Rrule" align="center" valign="middle">14
</td>
<td class="Rrule" align="center" valign="middle">(3, 26)
</td>
<td class="Rrule" align="center" valign="middle">10
</td>
<td class="Rrule" align="center" valign="middle">29
</td>
<td class="Rrule" align="center" valign="middle">(14, 44)
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top">    A/H3N2
</td>
<td class="Rrule" align="center" valign="middle">35
</td>
<td class="Rrule" align="center" valign="middle">22
</td>
<td class="Rrule" align="center" valign="middle">63
</td>
<td class="Rrule" align="center" valign="middle">(47, 79)
</td>
<td class="Rrule" align="center" valign="middle">31
</td>
<td class="Rrule" align="center" valign="middle">89
</td>
<td class="Rrule" align="center" valign="middle">(78, 99)
</td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" align="left" valign="top">    B
</td>
<td class="Botrule Rrule" align="center" valign="middle"></td>
<td class="Botrule Rrule" align="center" valign="middle">13
</td>
<td class="Botrule Rrule" align="center" valign="middle">37
</td>
<td class="Botrule Rrule" align="center" valign="middle">(21, 53)
</td>
<td class="Botrule Rrule" align="center" valign="middle">33
</td>
<td class="Botrule Rrule" align="center" valign="middle">94
</td>
<td class="Botrule Rrule" align="center" valign="middle">(87, 100)
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top"><span class="Bold">2001-2002</span></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top">    A/H1N1
</td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle">5
</td>
<td class="Rrule" align="center" valign="middle">14
</td>
<td class="Rrule" align="center" valign="middle">(3, 26)
</td>
<td class="Rrule" align="center" valign="middle">14
</td>
<td class="Rrule" align="center" valign="middle">40
</td>
<td class="Rrule" align="center" valign="middle">(24, 56)
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top">    A/H3N2
</td>
<td class="Rrule" align="center" valign="middle">35
</td>
<td class="Rrule" align="center" valign="middle">15
</td>
<td class="Rrule" align="center" valign="middle">43
</td>
<td class="Rrule" align="center" valign="middle">(26, 59)
</td>
<td class="Rrule" align="center" valign="middle">33
</td>
<td class="Rrule" align="center" valign="middle">94
</td>
<td class="Rrule" align="center" valign="middle">(87, 100)
</td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" align="left" valign="top">    B
</td>
<td class="Botrule Rrule" align="center" valign="middle"></td>
<td class="Botrule Rrule" align="center" valign="middle">6
</td>
<td class="Botrule Rrule" align="center" valign="middle">17
</td>
<td class="Botrule Rrule" align="center" valign="middle">(5, 30)
</td>
<td class="Botrule Rrule" align="center" valign="middle">32
</td>
<td class="Botrule Rrule" align="center" valign="middle">91
</td>
<td class="Botrule Rrule" align="center" valign="middle">(82, 100)
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top"><span class="Bold">2002-2003</span></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top">    A/H1N1
</td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle">24
</td>
<td class="Rrule" align="center" valign="middle">27
</td>
<td class="Rrule" align="center" valign="middle">(18, 36)
</td>
<td class="Rrule" align="center" valign="middle">52
</td>
<td class="Rrule" align="center" valign="middle">58
</td>
<td class="Rrule" align="center" valign="middle">(48, 69)
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top">    A/H3N2
</td>
<td class="Rrule" align="center" valign="middle">89
</td>
<td class="Rrule" align="center" valign="middle">42
</td>
<td class="Rrule" align="center" valign="middle">47
</td>
<td class="Rrule" align="center" valign="middle">(37, 58)
</td>
<td class="Rrule" align="center" valign="middle">85
</td>
<td class="Rrule" align="center" valign="middle">96
</td>
<td class="Rrule" align="center" valign="middle">(91, 100)
</td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" align="left" valign="top">    B
</td>
<td class="Botrule Rrule" align="center" valign="middle"></td>
<td class="Botrule Rrule" align="center" valign="middle">41
</td>
<td class="Botrule Rrule" align="center" valign="middle">46
</td>
<td class="Botrule Rrule" align="center" valign="middle">(36, 56)
</td>
<td class="Botrule Rrule" align="center" valign="middle">86
</td>
<td class="Botrule Rrule" align="center" valign="middle">97
</td>
<td class="Botrule Rrule" align="center" valign="middle">(93, 100)
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top"><span class="Bold">2004-2005</span></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top">    A/H1N1
</td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle">17
</td>
<td class="Rrule" align="center" valign="middle">28
</td>
<td class="Rrule" align="center" valign="middle">(17, 41)
</td>
<td class="Rrule" align="center" valign="middle">46
</td>
<td class="Rrule" align="center" valign="middle">75
</td>
<td class="Rrule" align="center" valign="middle">(63, 86)
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top">    A/H3N2
</td>
<td class="Rrule" align="center" valign="middle">61
</td>
<td class="Rrule" align="center" valign="middle">29
</td>
<td class="Rrule" align="center" valign="middle">48
</td>
<td class="Rrule" align="center" valign="middle">(35, 61)
</td>
<td class="Rrule" align="center" valign="middle">60
</td>
<td class="Rrule" align="center" valign="middle">98
</td>
<td class="Rrule" align="center" valign="middle">(91, 100)
</td>
</tr>
<tr class="Last">
<td class="Botrule Lrule Rrule" align="left" valign="top">    B
</td>
<td class="Botrule Rrule" align="center" valign="middle"></td>
<td class="Botrule Rrule" align="center" valign="middle">38
</td>
<td class="Botrule Rrule" align="center" valign="middle">62
</td>
<td class="Botrule Rrule" align="center" valign="middle">(49, 74)
</td>
<td class="Botrule Rrule" align="center" valign="middle">51
</td>
<td class="Botrule Rrule" align="center" valign="middle">84
</td>
<td class="Botrule Rrule" align="center" valign="middle">(72, 92)
</td>
</tr>
</tbody>
</table>
<a name="t7"></a><table width="100%">
<caption><span>TABLE 7 Summary of the Geometric Mean Hemagglutination Inhibition Antibody Titers, Pre- and Post-Immunization, for Geriatric Subjects
</span></caption>
<col align="left" width="39.140%">
<col align="left" width="11.219%">
<col align="left" width="13.736%">
<col align="left" width="13.736%">
<col align="left" width="11.519%">
<col align="left" width="10.652%">
<thead>
<tr class="First">
<th class="Botrule Lrule Rrule Toprule" align="left" rowspan="2" valign="middle">Year/<span class="product-label-link" type="condition" conceptid="4168796" conceptname="Muscle strain">Strain</span>
</th>
<th class="Botrule Rrule Toprule" align="center" rowspan="2" valign="middle">No. of subjects
</th>
<th class="Botrule Rrule Toprule" align="center" colspan="4" valign="middle">Geometric Mean Titer (GMT)
</th>
</tr>
<tr class="Last">
<th class="Botrule Rrule" align="center" valign="middle">Pre-vaccination
</th>
<th class="Botrule Rrule" align="center" valign="middle">Post-vaccination
</th>
<th class="Botrule Rrule" align="center" valign="middle">Fold Increase
</th>
<th class="Botrule Rrule" align="center" valign="middle">(95% CI)*
</th>
</tr>
</thead>
<tfoot><tr class="First Last"><td align="left" colspan="6" valign="top"><p class="First Footnote">* 95% CI: 95% confidence interval
</p></td></tr></tfoot>
<tbody>
<tr class="First">
<td class="Lrule Rrule" align="left" valign="top"><span class="Bold">1998-1999</span></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top">    A/H1N1
</td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle">13.92
</td>
<td class="Rrule" align="center" valign="middle">176.65
</td>
<td class="Rrule" align="center" valign="middle">12.69
</td>
<td class="Rrule" align="center" valign="middle">(8.24, 19.56)
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top">    A/H3N2
</td>
<td class="Rrule" align="center" valign="middle">42
</td>
<td class="Rrule" align="center" valign="middle">10.69
</td>
<td class="Rrule" align="center" valign="middle">124.92
</td>
<td class="Rrule" align="center" valign="middle">11.69
</td>
<td class="Rrule" align="center" valign="middle">(7.02, 19.46)
</td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" align="left" valign="top">    B
</td>
<td class="Botrule Rrule" align="center" valign="middle"></td>
<td class="Botrule Rrule" align="center" valign="middle">114.1
</td>
<td class="Botrule Rrule" align="center" valign="middle">273.56
</td>
<td class="Botrule Rrule" align="center" valign="middle">2.40
</td>
<td class="Botrule Rrule" align="center" valign="middle">(1.82, 3.17)
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top"><span class="Bold">1999-2000</span></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top">    A/H1N1
</td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle">15.82
</td>
<td class="Rrule" align="center" valign="middle">50.58
</td>
<td class="Rrule" align="center" valign="middle">3.20
</td>
<td class="Rrule" align="center" valign="middle">(2.13, 4.80)
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top">    A/H3N2
</td>
<td class="Rrule" align="center" valign="middle">34
</td>
<td class="Rrule" align="center" valign="middle">28.00
</td>
<td class="Rrule" align="center" valign="middle">133.19
</td>
<td class="Rrule" align="center" valign="middle">4.76
</td>
<td class="Rrule" align="center" valign="middle">(2.92, 7.76)
</td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" align="left" valign="top">    B
</td>
<td class="Botrule Rrule" align="center" valign="middle"></td>
<td class="Botrule Rrule" align="center" valign="middle">57.16
</td>
<td class="Botrule Rrule" align="center" valign="middle">127.86
</td>
<td class="Botrule Rrule" align="center" valign="middle">2.24
</td>
<td class="Botrule Rrule" align="center" valign="middle">(1.56, 3.20)
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top"><span class="Bold">2000-2001</span></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top">    A/H1N1
</td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle">6.66
</td>
<td class="Rrule" align="center" valign="middle">18.85
</td>
<td class="Rrule" align="center" valign="middle">2.83
</td>
<td class="Rrule" align="center" valign="middle">(1.91, 4.18)
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top">    A/H3N2
</td>
<td class="Rrule" align="center" valign="middle">35
</td>
<td class="Rrule" align="center" valign="middle">25.87
</td>
<td class="Rrule" align="center" valign="middle">140.68
</td>
<td class="Rrule" align="center" valign="middle">5.44
</td>
<td class="Rrule" align="center" valign="middle">(3.72, 7.96)
</td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" align="left" valign="top">    B
</td>
<td class="Botrule Rrule" align="center" valign="middle"></td>
<td class="Botrule Rrule" align="center" valign="middle">61.24
</td>
<td class="Botrule Rrule" align="center" valign="middle">191.23
</td>
<td class="Botrule Rrule" align="center" valign="middle">3.12
</td>
<td class="Botrule Rrule" align="center" valign="middle">(2.13, 4.59)
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top"><span class="Bold">2001-2002</span></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top">    A/H1N1
</td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle">12.69
</td>
<td class="Rrule" align="center" valign="middle">26.65
</td>
<td class="Rrule" align="center" valign="middle">2.10
</td>
<td class="Rrule" align="center" valign="middle">(1.55, 2.84)
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top">    A/H3N2
</td>
<td class="Rrule" align="center" valign="middle">35
</td>
<td class="Rrule" align="center" valign="middle">47.33
</td>
<td class="Rrule" align="center" valign="middle">114.26
</td>
<td class="Rrule" align="center" valign="middle">2.41
</td>
<td class="Rrule" align="center" valign="middle">(1.73, 3.38)
</td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" align="left" valign="top">    B
</td>
<td class="Botrule Rrule" align="center" valign="middle"></td>
<td class="Botrule Rrule" align="center" valign="middle">45.49
</td>
<td class="Botrule Rrule" align="center" valign="middle">91.89
</td>
<td class="Botrule Rrule" align="center" valign="middle">2.02
</td>
<td class="Botrule Rrule" align="center" valign="middle">(1.47, 2.78)
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top"><span class="Bold">2002-2003</span></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top">    A/H1N1
</td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle">13.29
</td>
<td class="Rrule" align="center" valign="middle">31.92
</td>
<td class="Rrule" align="center" valign="middle">2.40
</td>
<td class="Rrule" align="center" valign="middle">(1.90, 3.03)
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top">    A/H3N2
</td>
<td class="Rrule" align="center" valign="middle">89
</td>
<td class="Rrule" align="center" valign="middle">65.86
</td>
<td class="Rrule" align="center" valign="middle">272.79
</td>
<td class="Rrule" align="center" valign="middle">4.14
</td>
<td class="Rrule" align="center" valign="middle">(3.09, 5.55)
</td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" align="left" valign="top">    B
</td>
<td class="Botrule Rrule" align="center" valign="middle"></td>
<td class="Botrule Rrule" align="center" valign="middle">74.87
</td>
<td class="Botrule Rrule" align="center" valign="middle">288.57
</td>
<td class="Botrule Rrule" align="center" valign="middle">3.85
</td>
<td class="Botrule Rrule" align="center" valign="middle">(2.89, 5.13)
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top"><span class="Bold">2004-2005</span></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle"></td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top">    A/H1N1
</td>
<td class="Rrule" align="center" valign="middle"></td>
<td class="Rrule" align="center" valign="middle">21
</td>
<td class="Rrule" align="center" valign="middle">64
</td>
<td class="Rrule" align="center" valign="middle">3.13
</td>
<td class="Rrule" align="center" valign="middle">(2.33, 4.2)
</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" valign="top">    A/H3N2
</td>
<td class="Rrule" align="center" valign="middle">61
</td>
<td class="Rrule" align="center" valign="middle">72
</td>
<td class="Rrule" align="center" valign="middle">320
</td>
<td class="Rrule" align="center" valign="middle">4.43
</td>
<td class="Rrule" align="center" valign="middle">(3.13, 6.27)
</td>
</tr>
<tr class="Last">
<td class="Botrule Lrule Rrule" align="left" valign="top">    B
</td>
<td class="Botrule Rrule" align="center" valign="middle"></td>
<td class="Botrule Rrule" align="center" valign="middle">20
</td>
<td class="Botrule Rrule" align="center" valign="middle">114
</td>
<td class="Botrule Rrule" align="center" valign="middle">5.69
</td>
<td class="Botrule Rrule" align="center" valign="middle">(4.39, 7.38)
</td>
</tr>
</tbody>
</table>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="s40"></a><a name="section-12.3"></a><p></p>
<h2>14.3 Immunogenicity in Pediatric Subjects
</h2>
<p class="First">A small-scale study was conducted in 1987 to evaluate safety and immunogenicity of FLUVIRIN in 38 ‘at risk’ children, with <span class="product-label-link" type="condition" conceptid="201820" conceptname="Diabetes mellitus">diabetes</span> and/or <span class="product-label-link" type="condition" conceptid="317009" conceptname="Asthma">asthma</span>, or lymphoid <span class="product-label-link" type="condition" conceptid="315497" conceptname="Subacute leukemia">leukemia</span>.  Thirty-eight participants aged between 4 and 12 years of age were assessed.  Ten subjects had <span class="product-label-link" type="condition" conceptid="201820" conceptname="Diabetes mellitus">diabetes</span>, 21 had <span class="product-label-link" type="condition" conceptid="317009" conceptname="Asthma">asthma</span>, two had both <span class="product-label-link" type="condition" conceptid="201820" conceptname="Diabetes mellitus">diabetes</span> and <span class="product-label-link" type="condition" conceptid="317009" conceptname="Asthma">asthma</span>, and one had lymphoid <span class="product-label-link" type="condition" conceptid="315497" conceptname="Subacute leukemia">leukemia</span>.  There were four healthy control subjects.  All participants received a single 0.5-mL dose of FLUVIRIN.
</p>
<p>Immunogenicity results were obtained for 19 of the 38 subjects enrolled in the study.  The point estimate of the percentage of subjects achieving a titer of ≥ 1:40 was 84% for the A/H1N1 <span class="product-label-link" type="condition" conceptid="4168796" conceptname="Muscle strain">strain</span> 79% for the B <span class="product-label-link" type="condition" conceptid="4168796" conceptname="Muscle strain">strain</span>, and 53% for the A/H3N2 <span class="product-label-link" type="condition" conceptid="4168796" conceptname="Muscle strain">strain</span>.  The GMT fold increases were 5.8 for the A/H1N1 <span class="product-label-link" type="condition" conceptid="4168796" conceptname="Muscle strain">strain</span>, 40 for the B <span class="product-label-link" type="condition" conceptid="4168796" conceptname="Muscle strain">strain</span> and 17.7 for the A/H3N2 <span class="product-label-link" type="condition" conceptid="4168796" conceptname="Muscle strain">strain</span>.
</p>
<p>Three clinical studies were carried out between 1995 and 2004 in a total of 520 pediatric subjects (age range 6-47 months).  Of these, 285 healthy subjects plus 41 ‘at risk’ pediatric subjects, received FLUVIRIN.
</p>
<p>In a 1995/1996 clinical study, 41 subjects (aged 6-36 months) at increased risk for <span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">influenza</span>-related complications received two 0.25-mL doses of FLUVIRIN.  At least 49% of subjects showed a ≥4-fold increase in HI antibody titer to all three <span class="product-label-link" type="condition" conceptid="4168796" conceptname="Muscle strain">strains</span>.  HI antibody titers of 1:40 or greater were seen in at least 71% of the subjects for all three <span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">influenza</span> <span class="product-label-link" type="condition" conceptid="4168796" conceptname="Muscle strain">strains</span>, with increases in geometric mean titer of 6.0-fold or greater to all three <span class="product-label-link" type="condition" conceptid="4168796" conceptname="Muscle strain">strains</span>.
</p>
<p>Two clinical studies (1999-2000 and 2004) indicated a lower immunogenicity profile for FLUVIRIN compared with two commercial split vaccines; in a study in the age group 6-48 months the comparator was a US licensed vaccine, Fluzone<span class="Sup">®</span>, and in another study in the age group 6-36 months the comparator was a non-US licensed inactivated <span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">influenza</span> vaccine.  Despite the small sample size (a total of 285 healthy subjects received FLUVIRIN in these two clinical studies) the lower immunogenicity profile of FLUVIRIN was greatest versus the comparator vaccines in children &lt;36months but was also evident in those 36-48 months of age, though the differences were less.
</p>
<p><span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">Influenza</span> A (H1N1) 2009 Monovalent Vaccine should only be used for the immunization of persons aged 4 years and older.
</p>
</div>
</div>
<div class="Section" data-sectionCode="34093-5">
<a name="s41"></a><a name="section-13"></a><p></p>
<h1>15 REFERENCES
</h1>
<p class="First"><a name="p1"></a>15.1    CDC. Serum cross-reactive antibody response to a novel <span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">influenza</span> A (H1N1) virus after vaccination with seasonal <span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">influenza</span> vaccine. MMWR 2009; 58(19): 521-4.
</p>
<p><a name="p2"></a>15.2    Hannoun C, Megas F, Piercy J. Immunogenicity and protective efficacy of <span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">influenza</span> vaccination. Virus Res 2004; 103:133-138.
</p>
<p><a name="p3"></a>15.3    Hobson D, Curry RL, Beare A, et. al. The role of serum hemagglutinin-inhibiting antibody in protection against challenge <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infection</span> with <span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">influenza</span> A2 and B viruses. J Hyg Camb 1972; 767-777.
</p>
</div>
<div class="Section" data-sectionCode="34069-5">
<a name="s42"></a><a name="section-14"></a><p></p>
<h1>16 HOW SUPPLIED/STORAGE AND HANDLING
</h1>
<div class="Section" data-sectionCode="42229-5">
<a name="s43"></a><a name="section-14.1"></a><p></p>
<h2>16.1 How Supplied
</h2>
<p class="First"><span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">Influenza</span> A (H1N1) 2009 Monovalent Vaccine is supplied as a 0.5-mL prefilled single dose syringe, package of 10 syringes per carton.  NDC 66521-200-02
</p>
<p><span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">Influenza</span> A (H1N1) 2009 Monovalent Vaccine is supplied as a 5-mL multidose vial, individually packaged in a carton.  NDC 66521-200-10
</p>
</div>
<div class="Section" data-sectionCode="44425-7">
<a name="s44"></a><a name="section-14.2"></a><p></p>
<h2>16.2 Storage and Handling
</h2>
<p class="First">Store <span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">Influenza</span> A (H1N1) 2009 Monovalent Vaccine refrigerated between 2º and 8ºC (36º and 46ºF).
</p>
<p><span class="Bold">Do not freeze</span>.  Discard if the vaccine has been frozen.
</p>
<p>Store in the original package to protect from light.
</p>
<p>Do not use after the expiration date.
</p>
<p>Between uses, return the multidose vial to the recommended storage conditions.
</p>
</div>
</div>
<div class="Section" data-sectionCode="34076-0">
<a name="s45"></a><a name="section-15"></a><p></p>
<h1>17 PATIENT COUNSELING INFORMATION
</h1>
<p class="First"> Vaccine recipients and guardians should be informed by their health care provider of the potential benefits and risks of immunization with <span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">Influenza</span> A (H1N1) 2009 Monovalent Vaccine.  When educating vaccine recipients and guardians regarding the potential side effects, clinicians should emphasize that <span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">Influenza</span> A (H1N1) 2009 Monovalent Vaccine contains non-infectious particles and cannot cause <span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">influenza</span>. Vaccine recipients and guardians should be instructed to report any severe or unusual adverse reactions to their healthcare provider.
</p>
<p> Vaccine recipients should be advised that there are two <span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">influenza</span> vaccine formulations for this <span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">influenza</span> season, the monovalent pandemic (H1N1) 2009 <span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">influenza</span> vaccine and seasonal trivalent <span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">influenza</span> vaccine.
</p>
<p>Manufactured by:     Novartis Vaccines and Diagnostics Limited, Speke, Liverpool, UK
</p>
<p>An affiliate of:            Novartis Vaccines and Diagnostics, Inc., 350 Massachusetts Avenue, Cambridge, MA 02139 USA
</p>
<p>                                   1-800-244-7668
</p>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="de-a89c-0002a5d5c51b-jy-plpdp"></a><a name="section-16"></a><p></p>
<p class="First"><span class="Bold">Package Label - Principal Display Panel - 0.5 mL Pre-Filled Syringe</span></p>
<p><img alt="immediate container label, pre-filled syringe" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=fc5cfd1c-1ff5-4cfa-b544-db8d7f26d46f&amp;name=h1n1-figure-1.jpg"></p>
<p><span class="Bold">Package Label - Principal Display Panel - 10 Count Carton</span></p>
<p><img alt="carton label, pre-filled syringe" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=fc5cfd1c-1ff5-4cfa-b544-db8d7f26d46f&amp;name=h1n1-figure-2.jpg"></p>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="de-a1f2-0002a5d5c51b-jy-plpdp2"></a><a name="section-17"></a><p></p>
<p class="First"><span class="Bold">Package Label - Principal Display Panel - 5 mL Multi-Dose Vial</span></p>
<p><img alt="immediate container label, multidose vial" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=fc5cfd1c-1ff5-4cfa-b544-db8d7f26d46f&amp;name=h1n1-figure-3.jpg"></p>
<p><span class="Bold">Package Label - Principal Display Panel - 1 Count Carton</span></p>
<p><img alt="carton label, multidose vial" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=fc5cfd1c-1ff5-4cfa-b544-db8d7f26d46f&amp;name=h1n1-figure-4.jpg"></p>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong><span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">INFLUENZA</span> A (H1N1) 2009 MONOVALENT VACCINE 		
					</strong><br><span class="contentTableReg"><span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">influenza</span> a (h1n1) 2009 monovalent vaccine injection, suspension</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">VACCINE LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:66521-200</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">INTRAMUSCULAR</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">    
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong><span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">INFLUENZA</span> A VIRUS A/CALIFORNIA/7/2009(H1N1)-LIKE HEMAGGLUTININ ANTIGEN (PROPIOLACTONE INACTIVATED)</strong> (<span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">INFLUENZA</span> A VIRUS A/CALIFORNIA/7/2009(H1N1)-LIKE HEMAGGLUTININ ANTIGEN (PROPIOLACTONE INACTIVATED)) </td>
<td class="formItem"><span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">INFLUENZA</span> A VIRUS A/CALIFORNIA/7/2009(H1N1)-LIKE HEMAGGLUTININ ANTIGEN (PROPIOLACTONE INACTIVATED)</td>
<td class="formItem">15 ug  in 0.5 mL</td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:66521-200-02</td>
<td class="formItem">10  in 1 CARTON</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem"></td>
<td class="formItem">0.5 mL in 1 SYRINGE, GLASS</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRow">
<th scope="row" class="formItem">2</th>
<td class="formItem">NDC:66521-200-10</td>
<td class="formItem">1  in 1 CARTON</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRow">
<th scope="row" class="formItem">2</th>
<td class="formItem"></td>
<td class="formItem">5 mL in 1 VIAL, MULTI-DOSE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">BLA</td>
<td class="formItem">BLA103837</td>
<td class="formItem">09/15/2009</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler - </span>Novartis Vaccines and Diagnostics Ltd
							(239816320)
						</td></tr></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Establishment</span></td></tr>
<tr>
<th scope="col" class="formTitle">Name</th>
<th scope="col" class="formTitle">Address</th>
<th scope="col" class="formTitle">ID/FEI</th>
<th scope="col" class="formTitle">Business Operations</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">Novartis Vaccines and Diagnostics Ltd</td>
<td class="formItem"></td>
<td class="formItem">239816320</td>
<td class="formItem">MANUFACTURE</td>
</tr>
</table>
</div>
<p><div class="EffectiveDate">Revised: 10/2009<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>04366dc0-ba66-11de-a487-0002a5d5c51b</div>
<div>Set id: fc5cfd1c-1ff5-4cfa-b544-db8d7f26d46f</div>
<div>Version: 3</div>
<div>Effective Time: 20091016</div>
</div>
</div> <div class="DistributorName">Novartis Vaccines and Diagnostics Ltd</div></p>
</body></html>
